IS VISION. IT

VVITH A PALETTE

~

leGhr\,JOjie5

.1-

PROVI DES US

OF A IV\ILLION

HUES AND SHADES. IT GENERATES OUR HEALTH AND SETS

OUR IV\OOD. FROIV\ THE FLICKER OF A DISTANT GALAXY·

TO THE BLINDING FLASH OF A LASER, IT IS BOTH

TIIV\ELESS AND INSTANTANEOUS.

EXTENDED INTO THE ULTRAVIOLET AND INFRARED,

LIGHT IS THE ENERGY THAT ENGULFS ALL IV\ANKIND.

IT IS THE CATALYST THAT STIIV1ULATES THE LI FE

CYCLE OF OU R LAKES, RIVERS AND OCEANS. THROUGH THE

PROCESSES OF PHOTOSYNTH ESIS AND PHOTODECOIV1POSITION,

OPTICAL RADIATION IS THE CONSUIV1IV1ATE GARDENER AND

THE UL TIIV1ATE RECYCLER.

FRON'\ THE N'\ARVELS OF PHOTOL ITHOG RAPt-f Y TO

THE VVONDERS OF ENDOSCOPIC l.ASER SURGERY, ELECTRO-OPTICS

REPRESENTS THE FOREFRONT OF TECHNOLOGY.

THE POSSIBILITIES ARE ENDLESS.

p

December 4, 1992

Neil Gerardo

Office of the President-Elect and Vice President-Elect

President, Gerardo International 112 Water Turkey Court Daytona Beach, FL 32119-8710

Dear Neil:

I want to thank you for your letter of November 12. I appreciate your ideas and input, and have fOlWarded this information about MRX to our Healthcare Policy team.

Thanks again for writing.

:l Gene Sperlin Deputy Tran . on Director for Economic Policy

GS:mp

cc: Healthcare Policy '.

P. o. Box 8086, Little Rock, AR 72203·8086 501·374-3322 1120 Vermont Avenue, N.W., Washington, DC 20270 202·973·2600

MRX Technology: Projected Impact on Local Economy

Increased Employment: All pay levels, direct & indirect, non-seasonal, 3 shifts, 24 hours a day, 365 days a year.

Increased Tax Base: Augmented by MRX revenue stteam from exclusive global market.

Banking: . Primary and secondary effects: 4 patients per unit, SO-ISO units operatingaround the clock, $150-$1,500 diagnostic, $5000-$15000 curative therapy.

Real Estate: Increasing real estate needs and value due to the draw of new business to the area.

IntemationalRecognition: As a high level medicaVscientific/professional community.

Airport Use: Increased international traffic requiring full service customs facilities, duty free shops & a bonded warehouse to and from the only hospital on the globe with MRX.

Hotel and Motel Occupancy: Increased domestic & international travelers awaiting MRX appoinbnents @ 4 per hour per unit with 50 -ISO units in operation.

Lower Taxes for Residents: Substantial taxes paid for by MRX manufacturing and implementation at local hospital.

Blood Purification: The only certified blood bank free of viral contamination (HIV - Hepatitis A-B).

Insurance Company: Locally based to provide coverage at low rates for all MRX diagnostic and curative therapies.

Education: Increased tax base will provide sufficient revenues required to operate and maintain the highest quality educational system.

Reduced Medical Costs: Reducing insurance rates due to the increased amortization of insurance costs.

Lower Costs of Goods & Services: Reduced health care costs result in more competeive products and services. Increased profits, increased market share, increased expons and increased jobs.

Secondary Operations: Utilizing MRX technology with applications in photonic CatalyzatiODS with sea water de-salinization, phannaceutical processing, numerous electronic applications and hazardous/toxic waste elimination.

CAPACITY OF 150 MRX MEDICAL UNITS = 14,400 PATIENTS PER DAY -- MINIMUM ..••• ~

CASH FLOW BASED ON 4 PATIENTS PER HOUR PER UNIT = $9,000,000.00 PER HOUR.++++ (BLOOD BANK & ORGAN TRANSPLANT PURIFICATION NOT INCLUDED)

--------------- r

I t I

~orp f ecn I ecnnology Industry AnalysIs 15

Rankings by Projected Job Growth

The 20 Fastest Growing Rorida Companies Emerging High-Tech Firms « 1,000 em pI) Ranked by Projected Job Growth

, Jobs Company City PII_ Main high-lllch ICIivi1y SaIes(SmI PIgt

3 150 Harris CorpJAir Control 4· . ~ 100 Reptron ElectroiilCs.Jni:-: /K-Byte L1I 5 100 CCS Technology Group 6' _: .... ~85 MediTek.Health . ~~~ 7 m ~ In

~ .'::~'.~ ~~~~~j~;;;~~~~;~~i~~~~ 10 . - ~:':60 ·'N~J9wm.rid 11 50 Litton Systems, Inc. I Laser Sys. Div. 12 ·'::":::50Qu8drex.Corp.c~2~_~~"-",_ . , s 13 50 Pr.<:ilisilionllire, 14 Oro DATAMAX 15 50 Micro Design International, Inc.

16 '-' 50 CrestvieW Aerospace Corp; ':'.~:-:-"'~ '~~~~~5;~~~; ~r;·~:r:;:;~'-::~i'!l~::::?iflb ~~ .~~ ~~?~:! Corporation "7;:-;'-:::.:"1'" :,: =~: ;!,; . RaiiliijpjiiiiiiiE~~;i\:;~:Jm~ 19 ~ , 4O Openware Technology Corp . .. ____ _ ._ Jadcsonville ._._..........-lOO4I~71B? ~Jl!!!I!rS~ . ~!"-~~ 2D ,._40 Royce Laboratories,lnci.·.~ ,.. .. ~..:., .•• Miami · "_" _ .. ,",!m6Z4.'-150tl'. :tliliiilluotjfalfl'tA>'l&t! ";';:7&"':' l6.:J::::.:::;m-:;J i3ased on employment at emerging tedYlology m;r,ufac;ruters with under 1.000 the 12 months foIlcJwinQ the surwy . • - estimated. p. parent. employees .. Job •• number of new technology rnanufactunng Jobs prqected to( Source: CorpTech, Woburn, MA 18001333-8038

# 1 2 3 4 5 6 7 8 9

10 11 12 13 14 15 16 17 18 19 20

Top 20 Florida Cities Ranked by Projected High-Tech Job Growth

Jobs City Rrms Main high-tech activity .................. Jobs 1.709 Miami 61 Medical 1,417 J ,083 Tampa • --=': -":-', ' 60 Telecommunications -=--~-':'.J.il::.im,i

811 Jacksonville 30 Computer Software 512 758 Daytona Beach ' --,':-_.- .6 ' Medical . ,.' _ '. -.::: .:-~~.",.;),/;39l 586 Clearwater 35 Subassemblies & Components 400

_ 540 Orlando ... •... ~.:::.':;.,- 4 _Defense :,_ """"""""";::::':':xMW 525 Hialeah 7 Medical 482 491 Melbourne ' 7.;:3.. ,'~48 TelecomiTIIJruCationS:-:X:;,,::::~l89l 464 Largo . .. __ 15 Medical . _. _ .• _ ... _ _~ 404 .Sarasota . ,_ .... c." ... 27 ~Test&Measurement _ ·i;.;,:·~ . ·. . 378 Boca Raton 25 Computer Hardware 147 338 Saint. Petersburg. -=;';, .. 25 ; Environmental •. ': - ~'d6Qj 282 Gainesville 25 Environmental 181 259 Palm Beach .. ,~-:=::-.. '16 :.SubaSsemblies 8< CoriiiOOe.~' . j 3a\ 247 Winter Park 14 Defense 197 231 Pensacola ',"--:-'71:": 9. ~M8r!ufactUring Equiprrieii:t:;""" -:'7 -~ 229 Palm Coast 2 Subassemblies & Components 207 227 Fort: Lauderda1e.--::-;;':;;;C 34 . : re.\ecommunications .~;.'::: ":;'~K6$l 200 Maitland 8 Computer Software 129 195 FortWalton BeiiCfi '-~-'15 ,Defense =::r:-""~26i

Based on employment at firms with under 1,000 employees where the home office is In the city. Joba. nLnl­ber 01 new utchnology manufactunng Jobs protected fot the 12 months follOWIng the survey. Main hJ,h-ttdI .ctivity '" largest of 17 segments by employment; . , • • Job, • new lobs prolected WlltVn the maan ac:ovity.

Source: CQ(pTech, Wobum, MA 19001 ~8

Rorida

Technology Resource GUIde ... Flooda - ~ Copynght 1994. Corp)I'ate TechnOlogy Informatton SSIVIC8S. Inc.. Wotu'n. MA 16171932·3939. AJI ngms ..... -CORPTe~·

DUNS: 19-305-3758 :ERARDO INTERNATIONAL

DATE PRINTED DEC 16 1993

SUMMARY "'. . .... RATING -- ," ri-J... .

12 WATER TURKEY CT NO BRANCH(ES) OR DIVISION(S) 'AYTONA BEACH FL 32119

RESEARCH DEVELOPMENT & MFG OF ADVANCED PROCESSES & PRODUCTS FOR VARIOUS INDUSTRIES

STARTED 1976~ ~;~ SALES $+90,000,000-

.~

TEL: 904 756-1916 EMPLOYS ·iS17., -q ." .'iI!'.

iPECIAL :vENTS ,2/ 14/93

HI STORY .~ CLEAR . ~ • . ;. ,. , ~

..~~., ~ ... ; .-\ ;J 't .....

SIC NOS. 87 31 28 35

• . •• , . ..,J-. '1· ~.' ..i..~ '1i!. , .... . , .

"\ ,..., . ~ '" I .....,;:.. ". ,t. ~ ~ . .,--- """""" . . ,~. .... .~"----v

B' i' th f ~~\ ~) i ~ ~~ ted i th -US1ness s 1n e process 0 ~ecom1ng ncogorpora n e

first quarter of 1994. . (' :-..(,\..')0 ..... ~ ~ ,..., - . - . .~ ... "- .":"

PERATION _ 1\ ~.,S' ... "\ .~ ,~"\\ .~ 2/ 14/ 93 Advanced research. -:uevelopmenr..;.and manuf.,tnring of products,

processes and deviceS_1n ~iotechnaloqy, medtca~, energy Chemical, environmental, electronics, ge~~, agricultureL computers, defense, composi tes, sensors , and"1asers;~ 2i!Ircen~l!I!. brellKdown was unavailable,

Projects include ~e MRX.;,pr:a.iect wH;x:b'~ouples nuclear magnetic resonance and X Ray lasers;.~eqrad1nq toZic chemicals in water, soil and air; remotely detecting: and~· neutrali:z::Ulg chemical biological and nuclear weapon~Ii - deactivatio~of satell~tes, aircraft and m1ssiles in a time with no ' debris; encode/decod~b1nary at the molecular lever in 3 dimensions i:~lRAM' and ROM.j_ catalyse ... and control polygler processing wi th photonic·. and magnetic: coupled. energies and Coupled Photonic Catal1zation:.oProcessUlgi for higm.wl\1me "processing and refining of petrochemicars. MRK Medical conSists 0~el1minat1on of virus oacteria and tumors wi·thout.harmful sida. et"fects. The Genesis project exponentiates technological :~vaiution through mathemat1cal patterned correlations between 9LOOO+ ~1mdustries, 975 disciplines and all 76 game_theory model atral:eg;j.es.'g.

·The company. bas also computerized the ability to combine tecnnologies . fram- different disciplines and different industries. Terms are on a contract. basis. Sells to government and commercial concerns. ,'rerritory : l~ernational.

-~onseasonal. ',:'. f.. \, -· ;~lt EMPLOYEES: 517

.... ... ~ACILITIES: Leases 3,500 sq. ft. in one story concrete block . bU11d1ng~ . __

. ~ . ;.:~. . J;;OeATI ON : Rural section on side street. . BRANCHES: Additional research facilities are maintained at· 5

undisclosed locations throughout the United States. --, • . -12-16 (252 /252) 00000 059 059 .. , H

~"\.. . ,.-- ..

.,

NtlL GtAA"DO ",CltDC'"

II •• "fC" TUIIIC£T COU'"

DAYTOIfA 8&ACH. PI. 8"""'0

12 November 93 - FAX TO: 011-32-56-2583811 (1 Page)

Dear Luc: This may be of Interest to you In the Interim. Contact Ann Klemmer

at Dr. Dvorkovltz , Associates as well as Dr. Uoyd Patterson (2 Ph.D's)

who adv .. I_Sed __ Larry Nxe ___ :====:::~:::-:::~= i ....... ....- th.t h. had seen MRX work and It did Indeed perform ••• pecifled.

SXIliiifIAft UiLVil6ltiJ'1iUI&&i N se emf ___ ,.,W&--~* L1B 9 i ••

A tec:hnal.agy. - a proNIl ~ anI.tboci .­af tnata&Jt UBlJ ren1t:1DJ JA tt. care af riral 1nfect1ans, 1aa1ur::l.tng bJt not 11IIitsi to HIV V1rus (Amll. A set.ti!1cal1y prwen IIIItbcc1 by tGic:b tD ~y altar .-car tIIrcugb u. af pbaI:aW: c:ata11a-.Jcn

I Dr. Dvorkofttz & ~aodates. lac. fII,IPMONI: .... ,.. /. TaD: G6G3Zt A 0.. iax 17" ORMOND BEACH. FLORIDA 32171-1'. U.s.A. TlUFAXI~AQSlIUU!: IO ••• ,_

Description: MRX Medical - Couples and directs maqnetic and pbotonic ene~ to detect and destroy targeted virus.s, bacteria, fUDqi, C&Dcers and tumors in vivo.

CONTACT: LARRY NYE

tel-@.904-236-1207

r.f0!J({ PCllll.'l!OIl

dllll.'lllclllalulL

~Ast 1910 P.OHESTIC INDEPENDENT LABORATORY HAS DEVELOPED

A MAGNETIC RESONANCE X-RAY SYSTEM. IT HAS END-USE APPLICATION rOR THE TREATMENT AND ELIMINATION

P.O.80x994 Ormond Balch, Florida 32176 Tele,)hone: (00-1' 072·9';10 Fnclhnlllr. (904' 073·6027

or SUCH HEALTH PROBLEMS AS CANCER. HERPES. AND· HIV. ALSO CAN BE MODifIED TO PRODUCE VARIOUS ORGANIC CHEMICA~S AT HIGHER YIELDS WITH NO TOXIC SIDE-EFFECTS. A LABORATORY PROTOTYPE HAS PRODUCED ENCOURAGING RESULTS - DEGRADE MOLECULAR STRUCTURE INTO HARMLESS AND HELPFUL COMPOUNDS. OPTION/LICENSE ARRANGEMENTS ARE POSSIBLE rOR EACH END-USE APPLJCATION. PATENT APPLICATION IN PROCESS OF BEJNG riLED.

T 1994 Laser Facus World' Medical Lasar Buyers Guida lIfltlalW/orn ''all ,..,,,,.. bI ".", ttoz... . « _ ....

COMPANYINFoRwmnoN ~H .. CERARDO INTERNATIONAL

~ .. -------------------------------------------------------Addnss 112 WATER TURKEY COURT

~~ DAYTONA BEACH. FL 32119-8710 TeIepbaae: 901l-7S1-191& fa: 90-'2511-6796 DeclralKMIII: . Corporate u •• only

~ NEIL F. CERARDO

MatclqA' 3 ~af""'" CEORCE W. WILLIAMS aa.-caaaa(IadadeCldl) CEORCE BOWEN -DIRECTOR OF ADVANCED RESEARCH PROJECTS

~~(30"" .... ) a .... rdo Internatlon •• la. network of former goyemment employed sdentlat. of divers. disciplines po •••• lng dC'Clfmented scientific accomplishments

of precedent s.tUng significance.

DESCRlmOI OF PRODUCTS AND SERVICES (Umll to SO WOlds)

MRX - MOLECULAR SPECIFIC ABSORPTION USER SYSTEMS ACHIEVINC REMOTE

COUPLED RADIATIVE CATALYSIS FOR IN VIVO ELIMINATIONS OF VIRUS AND

BACTERIA WITHOUT AFFECTINC CONTICOUS SALUBRIOUS MOLECULES.

Antibody-targeted Photolysis of Bacteria In Vivo Francois Berthiaume~ Steven R. Reiken~ Mehmet Toner~ Ronald G. Tompklns~ Martin L. Yannush1•2 ••

'Surgical Services. Massachusetts General Hospital. and the Shriners Bums Institute. Boston. MA 02114. 2Depanment of Chemical and Biochemical Engineering, Center for Advanced Biotechnology and Medicine. Rutgers University. P.O. Box 909. PiscataWay. NJ 08854. ·Corresponding author.

We have evaluated the efficacy of antibody-targeted photolysis to kill bacteria in vivo using specific antibacterial photosensitizer (ps) immunoconjugates. Afttr infecting the dorsal skin in mice with Pseudo­molUlS aeruginosa, both specific and nonspecific tin (IV) chIorin e.-monoclonal antibody conjugates were injected at the infection site. After a IS min incubation period, the site was exposed to 630 DDt Ught with a power density of 100 mW/cm1 for 1600 seconds. Irradiation resulted in a greater tban 75% decrease in the number of viable bacteria at sites treated with a specific col\iugate, whereas nonnal bacterial growth was observed in animals that were untreated or treated with a nonspecific col\iugate. Antibody-targeted photolysis may be a selective and versatile tool for treating a variety of infections.

&ceir"wJ 6 JtlIUMJTY 1994: accepted 30 Marr:h 1994.

igh doses of broad spectrum antibiotics are required for many infections, ·particularly those in immuno­compromised individuals. Frequently, these antibi­otics can conttibute to organ damage. By targeting drogs directly to these microorganisms using mono­clonal antibodies, lower systemic doses of antibiot­ics may be used'-6. Antibody-drug conjugates can,

however, cause damage to nonnal tissue by virtue of certain nonspecific mechanisms (e.g. shared antigen cross reactivity, nonspecific binding, and increased vascular permeability at inflammation sites)7-1J. . .

One alternative for reducing the potential nonspecific dam­age to nonnal tissue involves the use of antibody-targeted pho­tolysis (ATPL). ATPL is a relatively new technique that uses antibody-bound photosensitizers (PS) which are toxic only upon activation by lightlZ- ll • ATPL selectivity exceeds conventional antibody targeting selectivity because only those conjugates which are activated by light generate toxic products. Further­more, activated coniugates produce phototoxins which have a very short range of action (100 run or less) which further limits cytocidal effects to the conjugate-bound targetsI9

•20

•

While the potential use of ATPL for the treannent of cancer­ous tumors in vivo has previously been studiedZI •21, applications of antibody targeting to microbial infections have been limited to imaging purposesIO.Z3.Z6. We have previously described the preparation of bacteriocidal monoclonal antibody conjugates directed against P. aeruginostJZ'-r7, a gram negative bacteria which frequently colonizes bum wounds. Bacterial killing in vilro using tin (IV) chlorin c; as the PS was shown to be highly efficient and likely mediated via the production of singlet oxy­gen and possibly other short-lived.species. The development of ATPL as a clinical tool for treating infections, however, requires that the cytocidal efficiency of the conjugate be assessed in vivo.

In this report, we demonstrate the efficacy of ATPL in killing bacteria in vivo using a simple mouse infection model and specific antibacterial immunoconjugates. The results of these studies show that specific tin (IV) chIorin ~-monoclonal anti­body conjugates directed against P. aeruginosa can specifically kill more than 7S % of bacteria injected in vivo.

Results and Discussion Properties of antibaderial immunocoojugates. Prior to

their use in ATPL studies, the physicochemical and photochemj-. cal properties of the immunoconjugates were evaluated using methods that we have previously described25. Purified conju­gates analyzed by HPLC and SDS-PAGE showed a single peak and a single band, respectively, which confirms the covalent nature of the bond between the antibody and the tin (IV) chlorin

c; groups. Previous biodisttibution studies of radiolabeled con­jugates have also established their stability in plasma25. The average equilibrium association binding constant to Fisher

i a: at :, IL CJ '0 1 c: o 1i l! IL

A • Dart ControIa B [] 80 Jlcm2

No ConI NS3.I C1:s7

Conjugate Type

0,. rn Vitro a,. rn Vivo. no Inc 0.. rn Vivo, 15 min Inc

o 20 200

[C1.37] (nM)

FIGURE 1. Killing of bacteria prefncubated with conjugates. A: Bacteria were prefncubated with no conjugate or 200 nM con­Jugate In the p ....... ce of O.5~ BSA for 1 hat 4°C, palleted, and resuspended In protein-free PBS. Open bars show the number of viable bacteria retrieved after expo8Ure to 100 mW/cm2 for 800 s at ooe In ,Itto divided by the number of bacteria Initially added to the preincubation mlxtu .... Closed bars are for dark controls. The conjusat- used ..... speclftc to P. 8aruglnosa with 1.37 PSiantibody (C1.37). or nonspeclftc with 3.6 PSI antibody (NS3.8). No Coni" no conjugate present during pre­Incubation. Mean ± S. E. II.; n = 4. B: Bacteria were prefncubated with O. 20, or 200 nil 8p8CIftc conjugate C1.37. Data showa the number of viable bacteria retrieved after expo­sure to 100 mW/cmJ for 800 • at O°C In ,Itto (0). after Injection In the mou .. skin and exposure to the same Incident light for 1600 • after no delay (0) or after a 15 min Incubation period (0). Data shown Is nannallud to the number of viable bacteria retrieved In similar experiments where bacteria were preincu­bated with no conjugate and exposed to no light. Closed sym­bols are for dart control •• Mean ± S. E. M.; n = 4 for In vitro data, n = 3 to 5 for In vlro data.

BIOITECHNOlDGY VOL. 12 JULY 1994 703

CCNY Researchers Dev.lop New Medical Techniques Two new patents for noninvasive optics-based medical diagnostics have been issued to R.R Alfano and his colleagues at the MedlphotoDica Laboratory at the City College of the City University of New York. The first deals With using Raman spectroscopy for dI-a osis of mali ancles. while the second involves using Raman s ectrosco to dlstln-gulsh atherosclerotic tissue om norm. ano an s group have been investigating such techriiques for more than a decade. These patents, along With others on fluores­cence spectroscopy for optical biopsy. have been assigned to or licensed by Mediscience Technology Corp.

Novel laser Action Ylel"s MI"-II Semlcon"uctor Device. A res~arch team led by Federtco Capasso at ATIlT BeD Laboratories has Invented a fun­damentally new kind of semiconductor laser that will make emission In the mid- and far­infrared reglon feasible. In their "quantum cascade" laser. reported in the April 22. 1994. edition of Science, stimulated emission occurs as electrons cascade down energy gaps en­gineered into adjacent quantum wells. rather than falling between the intrinSic energy bands in the material. "It opens the door to very important new laser possibilities. ones I hope wUl be pursued and achJeved." commented laser pioneer and Nobel Laureate Charles H. Townes.

Recor" Claimed for Optical Processor An optoelectrOniC processor recently developed by Eaeez Corp. of Columbia. Md .• report­edly has shown 93 dB of dynamic range (peak output signal to system noise floor). The company says that the combination optical and digital unit. based on its acousto-optic technology. perlonns signal processing at an equivalent rate of more than 60 TFLOPS using proprietary coherent processing techniques. According to the company's chief scientist. the dynamic range is a record for optical signal processors.

Ne. Fiber Said To Enhance Gyro Performance According to the UK firm Fibercore, a new version of its H1Bi fiber is capable of maintain­ing a stable and pure polarization state to -60 °C. The company says that in tests designed to simulate conditions encountered in a typical fiber optic gyro coil. extinction ratios of -30 dB have been maintained down to -40 °C With -27 dB shown at -60°C.

Splr •• eportl Ie. SI-8aseel InfrarecllED The ftrst demonstration of strong, room-temperature l.54-pm emission from erbium-im­planted porous silicon has been reported by Spin Corp. of Bedford, Mass. The firm says that the emission is 100 to 1000 times stronger than that of Er In quartz and almost at the level of InGaAsP, which is used for commercial IR LEOs. Spire said that no IR emis­sion was observed from Er-doped bulk 5i or GeSi produced under similar implantation and annealing conditions. and that the results indicate that high luminescence effiCiency results from the Er being confined in 51 nanostructures less than 5 DID in diameter.

Navy Clalml Ne. Laser Foils Gul ..... MI •• lle. A new solid-state IR laser that is capable of Jamming IR-guided missiles has been re­ported by the Naval Research Lab's OptIcal Sciences Dlv. The 2.09-lllIl Ho:Tm:YAG is pumped by laser diodes at 0.785 pm and delivers 40 W average power at room tempera­ture. The Lab says that a prototype has been developed. and airborne tests are scheduled for midsummer.

I" . • : ..... ;.~-

50 PHOTONICS SPECTRA JUNE 199

NEIL GERARDO

PRESIDENT

GERARDO INTERNATIONAL 112 WATER TURKEY COURT

DAYTON A BEACH. FL 351119-8'110

TELEPHONE (904) 7!56-1916

1 AUGUST 94 -- FAX TO: 011-0049-331-9675-222

MARSHALL BRICKEEN FOREIGN AQUISITIONS BRANDENBERG ECONOMIC DEVELOPMENT COUNCIL

DEAR MR. BRICKEEN:

THANK YOU FOR YOUR FAX OF JULY 28, 1994; IN RESPONSE •••••••

#1 •••• SEC. OF COMMERCE RON BROWN IS "WALKING MRX THROUGH THE FDA" FOR A FAST TRACK APPROVAL. ORIGINAL APPLICATION FOR APPROVAL WAS MADE ON DECEMBER 12, 1991. EVIDENTLY, IT HAS BEEN SITTING ON A "PRIMARY ADMINISTRATORS" DESK THAT WAS NOT ABLE TO REALIZE THE SIGNIFICANCE OF MRX. HOWEVER, DR. KESSLER HAS FIRED 4 OF THE LAST 5 YEAR DIRECTORS OF THIS OFFICE DUE TO TAKING BRIBES FROM CURRENTLY APPROVED COMPANIES WITH COMPETEING TECHNOLOGIES. THE ENTIRE SENIOR STAFF HAS BEEN FIRED 3 TIMES IN THE LAST 4 YEARS. WITH RON BROWN RECOGNIZING THE HUMANITARIAN AND ECONOMIC SIGNIFICANCE OF MRX ••••••• I DO NOT BELIEVE THERE WILL BE ANY MORE ••• IIIIDELA YS. 1111

#2 $100,000,000.00 U.S. FOR THE MRX MEDICAL FACILITY. AN ADDITIONAL $100,000,000.00 U.S. FOR THE R&D CENTER TO PRODUCE ADDITIONAL CARRIER FREQUENCIES AS WELL AS THE DEVELOPMENT OF ANCILLIARY APPLICATIONS OF MRX •••• ENVIRONMENTAL, ENERGY ••••• ETC ••.....• THESE INVESTMENTS ARE SUBSTANTIAL IN THEIR INITIAL IMPACT, HOWEVER, THEY PALE IN COMPARISON TO THE REVENUE THEY PRODUCE, $135 BILLION, U.S. PER YEAR IS REALISTIC AND ACTUALLY CONSERVATIVE.

#3 REFERENCE THE FOLLOWING PAGES WITH OUR RESPONSE TO BELGIUM. I AM SURE YOU WILL UNDERSTAND THE REALITY OF THE SITUATION.

#4 WE ARE A PRIVATE COMPANY WITH SECURITY EQUAL TO THE IMPORTANCE OF OUR WORK.

GERARDO INTERNATIONAL

NEIL G£R~.ROO

PRESIDENT

112 WATER TURKEY COURT

DAYTONA BEACH. FL 3~119·8'710

TELEPHONE (904) 756-'9'6

28 JULY 94 --- FAX TO 011-49-331-9675-222

MARSHALL BRICKEEN BRANDENBERG ECONOMIC DEVELOPMENT COUNCIL

DEAR MR. BRICKEEN:

I HOPE THE QUALITY OF TRANSMISSION IS GREATLY IMPROVED WITH

THIS FAX.

PLEASE LET ME KNOW IF THERE IS ADDITIONAL MATERIAL YOU

REQUIRE. WE HAVE THOUSANDS OF PAGES OF INFORMATION CONCERNING

MRX-MEDICAL.

THE IMPACT TO THE ECONOMY IS SUBSTANTIAL, HOWEVER THE

$135 Billion U.S. ANNUALLY IS ACTUALLY QUITE SMALL WHEN YOU

CONSIDER THE FACT THAT A SMALL PERCENTAGE OF MANY COUNTRIES

HEALTH CARE BUDGETS WILL BE FLOODING INTO BRANDENBERG AS A

RESULT OF AN MRX MEDICAL FACILITY LOCATED THEIR. AFTER WORKING

WITH THE ECONOMICS OF IT FOR 3i YEARS, WE NO LONGER ARE IMPRESSED

WITH THE AMOUNT, RATHER WE FOCUS ON THE NUMBER OF LIVES WE CAN

ENRICH WITH MRX-MEDICAL.

RWARD TO HEARING FROM yOU ••••••••••••

eve 0 ments to ate _ EDITED BY RUTH COXffiR tists at the University of Alabama and LXR .

Inc. in Richmond, Calif., discovered that victims of systemic pus erythematosus, an autoimmune disorder, have abnormal

SHEDDING UGHT ON amounts of a short version of a protein called Fas. Normally, THE UVES A all Fas proteins attach to cell membranes and play a role in f------~r--:-----_r_=~_:_---_;_"""7_1 causing cell death. But the short versions lack the membrane-.

Astronomers take the binding section, so they float around in the bloodstream, pre­temperature of the venting the normal "death" signal from reaching the cells.

sun and stars by analyz· Healthy mice injected with the shert Fas protein quickly devel· ing the spectrum of the op an autoimmune disease. The scientists therefore suggest light they emit. Now, that extracting this protein from the blood of patients might Purdue University re- offer a simple, effective treatment. searchers are using light f-----'-------------------j to measure temperature in tiny, nearby places, in· cluding the interior of single cells.

A MIlKY WAY TO NEW PRODUas

Researchers shoot a M ilk may but a surplus has dairy farmers pulse of laser light at an seeking new markets. So they're paying 15¢ on every object through an opti- 100 pounds of milk to fund promotion and research. The re­

~~=-~~~~~~7::::=:;~J c8I fiber. Some light suits so far range from edible packaging to tidier yogurt. bounces off and comes back up the fiber. By precisely measur- Cornell University scientist Carl A. Batt and his colleagues ing the changes to the light, it's possible to determine not only have taken a close look at a milk protein called beta-lactoglob­the object's temperature but its internal pressure and compo- ulin. By substituting one of its amino acids for another, they've sition. "We're asking different questions of the same sample of improved milk's gel-forming properties. That means yogurt light," says Dor Ben-Arnotz. a physical chemist. These '"molec- won't "leak" pools of liquid when stored, which some consu­ular thermometers" could be used to gauge the quality of mers consider a sign of spoilage. Beta-lactoglobulins might microcircuits on silicon or the lubricity of a micron·thin layer even be used for delivery of oral medications, says Batt, of oil between metal parts. Dow ·Chemical, 3M, and BASF are since they pass undamaged through the stomach. interested. Further down the line, Ben-Arnotz predicts, such Another milk protein called whey is being converted into ao devices will inspect the metsbolism of living cells. edible film by John M. Krochta's research team at the Univer-----------------------j sity of California at Davis. The film is a superior oxygen bar­

HOW SOUR NOTES W RGHT CREDIT-CARD FRAUD

rier that can extend the shelf life of crackers and nuts. That would reduce the amount of packaging households discard and eliminate the need for BHA and BRT preservatives. It could be available in a year or two, says Krochta.

W hat's noise to one person is music to another. In fact, the "noise" in the magnetic strips on credit cards could

soon be sounding sweet to banks by helping them cut down on FOR HillERS WITH WARNING-TRACK credit-eard forgery. Researchers at Washington University in POWER: A DlMPID BAT St. Louis, led by Ronald S. Indeck, an electrical·engineering r=--;-;-7":":'--:--::---,,------------i professor, discovered that even tiny patches of magnetic me- cov- q;J" dia contain a pattern of minute magnetic particles as unique as ered with dimples. / / a fingerprint. So maybe it makes sense / /

Today's credit-card readers are designed to screen out the that tomorrow's baseball noise caused by these particles and concentrate on the record- sluggers may swing a ed data. But with an inexpensive semiconductor chip, readers dimpled bat. Jeffrey C. can pick up and analyze the noise signal, extracting a card's Di Tullio, an aeronautics magnetic fingerprint to verify whether it is genuine. The instructor at Massachu­technique e;an't prevent stolen cards from being used, lndeck setts Institute of Tech­concedes, but credit-card forgery now costs banks hundreds of nology, was working on millions a year. Lowy Technologies LC, a St. Louis tech-trans- a classroom exercise on fer company, is negotiating with the university to act as its li- reducing drag on cylin­censing agent. ders when it dawned on

f---=-=:..------------------i him that baseball bats could benefit.

DO SHORT PROTEIIIS HAVE A LOIIG Adding bumps to roughen a smooth surface and improve its

RECORD III AUTOI_UIIE DllrrArE$? aerodynamics isn't new. But raised bumps would scuff a base-

•~H~~~~~~~~~~~~~~~ .. ~~·~~~ ball-and help pitchers throw bigger curves. Instead, Di Tul-

O ne of the keys to good . lio pressed tiny dimples into the bat. They reduce drag by balance between the- life and death of cells. causing turbulence on the bat's surface. where the air normal-

, !mow that glitches in the mechanism that kills off certain ly flows slower and causes the most drag. The result: A hitter immune-system cells can lead to serious "autoimmune" diseas- can swing a dimpled bat 3% to 5% faster. which translates into es-with the immune-system cells running amok and attacking an extra ill feet to 15 feet on a long drive. Di Thilio. who re­the wrong targets. Now, scientists are beginning to understand ceived a patent in February, says nothing in pro baseball's rule why that happens. book would ban such bats, although he expects amateur teams

In research reported in the Mar. 25 issue of Science, scien· to try them out first.

OENCE &. TECHNOlOGY BUSINESS w !:EK/ A.PI!lt 4, 199.4 95

I)! ~p AIDS researcher ~!!~~~!.~~~c!n~!~~,:!or'?!:~vaai~ ,.. r-=iiiii.------------ body. The proteins aUmulate the body'. Immune .,.. c:ould be develoPed ror the mucus membranes --G tem to produce anUbodlea that protect celli hill In- where sexual transmission 01 HIV takes place - that . ~ PARIS - A prominent French AIDS researcher vadinl vlNses, such as HW. would allow the membranes to protect themselves. as 8IYI lCIenUata can 10 no further In thelr efforts to Montagnier said vacclnea teatecl 10 far on volun- "rm not SQins there won't be 8 vaccine," Montag-

J 2 produce an efl'ectlve anU-AIDS vacclne and must teen have succeeded In triUerinl the production of nier said. "In any case it will take a lon)l time and it > DOW explore new WQI of maJdna one work. antibodies apinlt only one strain of won't solve e rosie. We hive to fOresee fivin C -rbiI is the time to rethink the VlCClne \Mauae undreds 010 rs CI the lint avenues we explored are WIOnI. 'ftley have ore E reached a clea4 end," said Proleuor Luc Montapter. Montalnler~. ;:~'t=-these fint vaccines,

_II ~ He was one of the lint adenS to IiOIite 1&i1iu- while not reliable. have Idvaneed resean:b ef1'orts. ~ C man lnununocleJlclenq vIIUI that ca1IIe8 :AIDS. lfontqnler aid re.earehen should tq to develop

. (I)

MRX HAS BEEN PROVEN AS AN EFFECTIVE APPROACH AGAINIST ALL STRAINS OF HIV. AS THE SINGLE CURATIVE THERApy cApABLE OF THE IN VIVO ELIMINATION OF THE AIDS VIRUS WITHOUT CAUSING MUTATIONS OF THE VIRUS, WHICH PAST ATTEMPTS USING VACCINES CAUSED. ANY ATTEMPT TO "CURE" A VIRUS USING ORGANIC CHEMISTRY AS HAS BEEN THE HALLMARK OF THE FAILED ATTEMPTS WITH VACCINES, DRUGS, ••• ETC •• • IAS NEVER PROVEN TO BE EFFECTIVE IN THE HISTORY OF LIFE ON EARTH ••••••••••••••••• IDENTIFING THE COMMON COLD AND THE COMMON FLU AS NEVER BEEN "CURED" BY ORGANIC CHEMISTRY SHOULD HAVE BEEN A CLUE NOT TO CONTINUE IN THAT SAME FAILED DIRECTION ••••••• AFTER MILLIONS OF ATTEMPTS OVER THE LAST 5' yEARS, ••••••••••••••••

USING MRX •••••• AN ADVANCED COUPLED X-RAY LASER •••••• IT IS NOW POSSIBLE TO CLEAVE (BREAK APART) SPECIFIC MOLECULES (HIV--ETC) INCLUDING VIRUSES AND BACTERIA WITHOUT EFFECTING ANY OTHER MOLECULE ••• YES •••• THE "SI LVER BULLET" THE MEDICAL WORLD HAS BEEN WAITING FOR HAS ARRiVED •••••• AND IT IS CALLED MRX.

THE FIRST MRX MEDICAL FACILITY IS BEING LOCATED IN KORTRIJK, BELGIUM A FEW HOURS DRIvE FROM PARis.

*******For additional Information contact: Luc Debusschere In KortrlJk ITaI: ~5&)(M](16X 32-56-239151 or 32-56-213667 Fax: 32-56-239003

In the United States, contact George W. Williams ITel: 90"-756-1916 @Gerardo I nternational Fax: 90"-756-"300

VERY IMPORTANT TO NOTE ••• THE PUBLISHED "INFECTION RATE OF HIV" IS HIGHLY INACCURATE. IT IS NOW APPARANT THAT THE CURRENT TEST ONLY DETECTS HIV -1 WITH A HIGH DEGREE OF ACCURACY. THE "HUNDREDS OF OTHER HIV STRAINS" DISCOVERED BY PROFESSOR LUC MONTAGNIER ARE AS DEADLY AS HIV -1 ••••••• HOWEVER •••••• THE CURRENT TEST IS USELESS IN DETECTING THESE HUNDREDS OF OTHER DEADLY STRAINS.

.sClennsts Worn~dI>Y·

. . ..' . new· battena

.......... _- ~_''''I •••• ~

By PAtJL·iiADtJRN ":. " ............. . SAN FRANCISCO ':' Comindb

bacteria that cause DDlUDi'oDia. children's ear lDfectloDS aDd many other dlsea- are evolvtq IDto forms UDtrel.table by an ImoWll medicines, tbreateninl a CbtlJtnl post-antibiotic era tbat would be '-Uothiq shGrt of a medlcal d1uI­w. ,. a reaearcher said Saturday. .

In tile poIt-mtiblot1c world. tile simplest iDtect10Da could qu!cIdJ. eecalate Into rata1 fD"_. said AI­. ·,nder TomaII of RocUleIler UDi· versity III New Yark CIty.

"Molt people tIUDk It will bap. pea." be sUd. !'It's UDpndlctabIe 1rbIIL" ADd tile ~?"No ODe Jmows. TIle mortality .. qalte bfIb." . . ".

'DIe 'tInt atiblot!c; peafcQ1tn. becIme wtdIb' available m UNO. for 50 ,.us. IDOIt t.derial bIfec. do. have '-tl tr.tabJe. . .. ~

But staiD nnmmmm bIdIr1a a1reIdJ baw cIeveJoped una.table ..... ADd Iaboratar7 aped. IDIIdI bave praftIl tbat die .....

...... -SEE MCnIIW ,~

o Bacteria

22 FEBRUARY 9'1 --

LUC:

CNN+AP+HEADLI NE NEWS+ABC+CBS+NBC IS RUNNING THIS STORY OF "POST ANTIBOTIC ERA" OF UNTREATABLE INFECTIONS RESULTING IN DEATH ••••••••••••••••••••

WITH MRX •••••• THERE IS NO POSSIBILITY OF RESISTANCE AS THERE IS TO ORGANIC CHEMISTRY ATTEMPTS WHICH HAVE CAUSED THIS PROBLEM BY MUTATING THE BACTERIA AS WELL AS THE VI RUSES •••••••••••••••

NO MUTATIONS WI TH MRX •••••••••••••

NO BACTERIA CAN SURVIVE MRX ••••••••••

NO VIRUS CAN SURVIVE MRX •••••.•••••

WE WARNED ABOUT THIS IN 1971 , 1972 ••••

WE IDENTIFIED THE PROBLEM AND THE SOLUTION BEFORE THE PRDBLEr., BECAME AP.PARENT •••••••••••••••••••••••

LUC ••• THIS IS PRIME MATERIAL FOR DE ST ANDAARD ••••••••••••••••••••••

KORTRIJK IS GOING TO BE THE ONLY PLACE ON THE FACE OF THE EARTH WHERE THESE INFECTIONS CAN BE CURED •••• NOT MERELY TREATED •••• BUT CURED •••••••••••••••••

LET ME SAY ONCE ACAI N •••••••••••••••

""WE CHOOSE KORTRIJK, BELCIUM BECAUSE WE BELIEVE IT IS THE MOST ADVANTAGES LOCATION TO CONDUCT GLOBAL BUSINESS.'!'!'!

"VIE AT GERARDO INTERNATIONAL ARE IMPRESSED WITH BARON E. de BETHUNE'S ABILITY TO FULLY COMPREHEND, GRASP AND REALIZE THE MRX TECHNOLOGY'S CONTRIBUTION TO GLOBAL HEALTH AND ECONOMICS. lin

"BARON E. DE BUTUNE'S VISION IS ILLUSTRATE AND SUPPORTED BY PETER PDIT" THE HIV SPECIALIST FOR THE WORLD HEALTH ORGANIZ} TION IN CENEVA, WHO RECENTLY STATED," IN SPECIALIZED AMERICAN PUBLICATIONS THEY S. AND WRITE THAT MRX HAS PUT SCIENCE ON A HIGHER LEVEL"II" ••••••••••••••••....•••

NEIL GERARDO

PRESIDENT

GERARDO INTERNATIONAL 112 WATER TURKEY COURT

DAYTONA BEACH. P'L 31119-8710

rELEPHONE (904) 756-1916

27 APRI L 94 --- FAX TO LUC •• @ 011-32-56-258384

LUC:

I BELIEVE YOU NEED TO LOOK AT THE MRX PROJECT FROM ANOTHER DIRECTION TO UNDERSTAND IT'S TRUE SCOPE. IN THE U.S. THERE ARE APPROXIMATELY 2 MILLION (according to the American Cancer Society) NEW CANCER CASES DIAGNOSED EACH YEAR AND THERE ARE 526,000 DEATHS (National Cancer Institute) PER YEAR. THE AVERAGE COST TO TREAT A CANCERVICTIM, FROM DIAGNOSIS TO DEATH, VARIES FROM$100,000.00 TO $300,000.00 ($382,000.00 according to the American Medical Association). MRX PROVIDES A CURATIVE TREATMENT FOR APPROXIMATELY $5,000.00 TO $15,000.00. (maybe you can understand the financial motivation for the opposition to MRX).

TO TREAT 2 MILLION PEOPLE, DIAGNOSED WITH CANCER, AT KORTRIJK WOULD REQUIRE 5,000 747 flights (400 people per flight) to and from Kortrijk PER YEAR, OR 13. 7 747 FLIGHTS PER DAY. 5,480 PEOPLE WOULD BE ENTERI NG AND LEAVING KORTRIJK DAILY, EACH NEEDING FOOD, SHELTER AND TRANS PORTATION. THIS DOES NOT TAKE INTO ACCOUNT THE FACT THAT MANY O-F THESE PEOPLE WILL BE TRAVELING WITH FRIENDS AND/OR RELATIVES.

TREATING ONLY THESE DIAGNOSED CANCER PATIENTS FROM THE UNITED STATES ALONE AT AN AVERAGE ESTIMATED $10,000.00 PER PATIENT GENERATES A REVENUE FLOW OF $54,800,000.00 PER DAY OR ABOUT $20 BILLION PER YEAR. ~ THIS IS FOR TREATMENT ONLY. ADD TO THIS THE CANCER CASES FROM ~, CANADA, UK, FRANCE, SPAIN, GERMANY,AUSTRIA, FINLAND, ITALY, ETC •••• ~l AND FACTOR IN MRX'S USE FOR CURATIVE TREATMENTS OF VIRAL INFECTIONS ~ (HIV, HANTAVIRUS,HEPATITIS,HERPES, VIRAL MENINGITIS, ETC.... BACTERIA~ SUPRAINFECTIONS, AND OTHER DISORDERS, YOU MAY BEGIN TO UNDERSTAND THE MONUMENTAL SCOPE OF THE MRX MEDICAL FACILITY IN KORTRIJK.

LOOKING FORWARD 10 YEARS AND COUPLING IN OTHER PLANNED PROJECTS THE FACILITY WILL QUICKLY EVOLVE INTO A CITY OF ITS OWN. WE ANTICIPATE 700 ACRES WILL ONLY BE THE BEGINNING. THE ONLY OBSTACLE REMAINING IS PENDING NEGOTIATIONS WITH THE FEDERAL GOVERNMENT. NEIL

LUC: AFTER OUR SECURITY CONFERENCE ON MRX, WE HAVE DETERMINED

THAT BECAUSE SO MANY UNIVERSITIES, MEDICAL SCHOOLS, MEDICAL

~'eSEARCH LABORATORIES AND INDEPENDENT RESEARCH LABORATORIES

THROUGHOUT THE WORLD ARE RACING TO DUPLICATE THE MRX TECHNOLOGY

WE WILL REFRAIN FROM DISCLOSING ADDITIONAL INFORMATION UNTILL AFTEF

THE MRX MEDICAL FACILITY IS OPERATIONAL IN KORTRIJK, BELCIUM,. .~H~ ... AND COMMERCIALIZATION IS COMPLETE ON CHAMELEON & MERLIN THE NEXT GENERATION OF MRX TECHNOLOGIES WITH SUPERIOR CAPABILITIES WHICH WILL RENDER THE CURRENT MRX TECHNOLOGY OBSOLETE ..

AT WHICH TIME ••••••••••••••• A WHITE PAPER ........ WILL BE ISSLEO/if'

N~uJ)~ /' /3/Q V :;: , (S) w -f.

~'D ~ : r.:,i w· ----------------------------------------------_._-_._---_. 9 flo)

Stad leeft tussen geloof en hoop (omt Amerikaans bedrij( Gerardo International toch aan de Kulak? : KORTRUK - De kans bestaat TochklonkGnoitwlJfcllnckstan OJ~ heasl. Is bfpIJpbur. EIR .f Ie kgm". I

I at de Amerikaanst l'tSearch van burp:criftsler Sanscn. toen cIe2 De ~trale Ilalnl In Europa. de nIcuwe Slap In welke Wdmscblp oak £en unleke klns wor KorcrQk om w • _ - tlJdms de ..... ndcDjw pastonre- mcauUghdd en de produblvltdl bedt aanvankdlJk Immm al Ie reb- mel em cleqellJl bedrljf op zIjn

roep Gerardo InltmallOnal zich Imlk van Iisiam. de Amaibanse wan. VImIlnsm m de InmskwaU- om mel em soon onldool. Ok tol lrondgebled de 21slf mIW In Ie stap-f1 de buun van de Kulak, de vndslnl bdenclmaoakte. . teit die land en suuk kunnm bledal IIIOdm nktnft ontcfdldnsCD nu pen. vtndt Lac Debusschae dan ook. ~ortrijkse uni~tsileil. komi ves- un bultmlandse wnkncmers warm emmaaI bdalm". KOr1r1Jk moft die kans. weliswaar igen Dat think-lank" uit Day- .. WlJ mUm BftII mossden roqm * bdanBriJkste UJUIDellien 1m K.rim1n I IMI de nod~ nuchterheld. aanRffJ·

. :' woor.~r de stoep un wal Is. Mocbt wonIele van de vnIl,lnlln KonrlJL. ee pen. m memt hiJ. ona Beach In Florida sidl 500 ge- het ulldnddljk loch op em slsser Wat voor KanrlJk hoe clan ouk .. Ids em Siad van sl«hls 2'.000 In· ~ ~rden tnvtlk. Etn '-an dt aJuivi- ui.dr~ dan wDIm wlj OIlS nIct bet Ongeloof ~"nlrljk Is. vlnd. Debussc:bae, zijn wonen erill silas' de OI)'1nPtsc:h~ ~ cilrn is gerichl op de behande- wawiJt moetm makeo dal we u Rids Genrdo Inlernational zql In de * invnlerlns. • tewakstetlinjs- wfntenpdm binnm Ie halen. dan Is E ing van unlter- to aids-palim- YOOI'ledunhdJbm .... aklus.burJe· kommde vljl jur IOOmUjomdoUar bnsm en de splno-ofl-mosdijkhc· hel omdal U da.~ wnklm. iii

• •• • 1RiI!nln. k wIleR llweslefen In hel pmJekl. In den. IR ftR ftUIe faR- ...... ~.. WMf8111 aMI ftft 'I" \'8t1 76.009 1ft. ~ en. Precle5 ID dll domem zoekt ~ ondahanckllnsm met GftanIo em ftlSte faze - sued ¥VOl' 25 mU- 500 ptiSCHim wak vtndm biJ Gaar· woncn dan sem belanJrljk beclrtJI 0

lei bedrijf in KOllrijk etn VtSti- stadlm wriI jaar In februarl. VI)f )om dollar - wD lid bedrIJf em me· do. met ceo wadclprlmftIr kunom bin· ~ )ing Uil Ie bouwtn. Em investe- munden lata bnochl ftII bedrQrs- disdl behancfelinpcallrum en un- .. Hd zuu btmlnerl zIjn wanMer nenhalm1 AIle bedrijvm kunnrn ~ ~. 100 mil' d lia deleSill1e kondjk en voade ~:onder vawante rnean:haklivhdlen ulIbou· ItarUljk dc:r.e aDS nId zau pIJpm.'. lOch nlctla Tokio. Parijs of New York ~ f mg van ~oen o. r en ceo mrcr snJftkken met mmsm wan MIl in Kortrfjk. Bdde zljn ~ wamchuwt DdJusscbae. .. vaaraI aewsllad wurdmr JerwaChle lnvrrkstelhng van 11001 Xonttjk. de Inamommunak op em nlNwf am.noJosk, MRX F- wa~ Khleraf IOU blljkm clal *s 150 haag gek\YalifKetlde men- .l.dcdaI m lid ~ nn minister naamcL die zkh onckr IIIftI' tocspllSl kIopt en dat we af,esarafl worden EInd april ¥el'\yachl Konrljlt * . en IO brei hel Eind april komen W.IMkt. up de bdlanddlns van unltcr en wesms em Ie II'OOC skepddsme. Te wcelbclormck Amuikanm. Pas dan '. .' • Op I) oklober sIeed de ru binDm aJds. mea dar em bcdrfll dal em omzd ul duidetijk wordm of hoop oolt 'Ie Amenkanm mar KortriJk om biJ Lue DdJusscheR van ntuM be- Het ~jr weisert vooralsnos M- hu11 van 251 mlljoen cIohar. 10 ....,r Floor lean wmIm. er het konlrakt rond de grondaan- Irekkingm. hel kablMt van sc:bqJaI tmschappcUjStr details vrij Ie snm. dJn gdoofwaardlgJu:1d ok, op bet koop Ie onderttkenen. de Belhune: het wmI KOItnJk. Luc Debussd1er~: ... o.t er em zder spd lal !tum door Iosse vnltlarinlen Gmt. LUTS

-.- -- ---- --- _. -- _ ..... _----

s I w

,.

~M v IfN Maandag 28 lebruan, . 1994 9'· J r. J

Kortrijk krijgt exclusief medis~h centrumJ . . ~. ~. .

Amerikanen investeren 3,6 milj#d voor 500 jobs KORTRIJK - De Amerikaanse met eeo oinzel van 157 mlljoea wordt in eeo eente rase 2S miljoea . 8roep ~,."nIO 'me,,",,;""'" I..... dollar. BiJ eea IntentieY~1 dollar or eea klein miljard gcioyes-. plan OlD op eea teneiD naast de OlD zlcb miuchleII In Korttijk Ie lead in een viJRI.ta. bebande:- . Kortrijbe anlyenllell em beIwI- velli ... bleer het aiel want op 13 liolseeabedeo. ' . 6~

. deliDllCelllrUm ell oacIermebaf· ott ....... J .. wad de eer*r" ~ komea er 150. BebalYe dil l

. .... uk Ie boa.... ..... opde op ... yall"", ia behanclellnpceDbulli. lloqJI de Ie- ~ OeIpreici Ofti' yJjf jur is er eeo In- Kortrijt plldd.' seareh-afdeUnl de tal .... bet pro-yesterlal mee lemoeid ya 100 . In april wordl de AmeribaQSe . jed op, ••• de lotale tnvesterllil , miljoea dollar or 3,6 mlljard frank. poep Mer venracht voor de om-· op 3,6 mlljard bIen.l. Bianen de .~: ID de kliniek _lien balterpaden- eille juridilcbe ...... 'i .. ya de" vljr jaar mueten er 4SO medewa-teD ea semposltieven zich.hIUIea ~. ken lobal worden lerewteerd ... t IaIea bebaDdeleo. EeIUDUl op Het bedrijr GOlwiklelt de MRX... VijRlI welenscbappers tomen. buillnelheid. lerandeert de II'Oep technoloaie In de behandeUnl yan oyer uit Amerib. vljfhonderd jobs. padeateD die lijdeD an baker. Of hel bier aiet om een Ameri-

Oerardo International onthulde HIV -besmeu.ina of aadere !evens- bans sprootje ..... Y1'Oegeo we zija plaanen cenl in Jaet weckb.... 8ev .... lijb •• ndoeniDlen. Mel Luk Debusscbere: ..AllenninsL De .' TrftIIb. De Kortrijkse schepea' MRX - wat ..... yoor "",M,1e AmeribDen" veRoun Konrijk·, Emma....,1 de Bethaae wrtoos lit RaI4Ilmc. x-a", ,..., - wordI boYea "Ie aadese ftSIilinlsplaal- • zwijlell tot de laVeileriol deliai- "de '"'I die de twucta.diae celleD . sea weaellS de lunsdF lialnl in . tier billDel1 is.' I • is bet llcbaam vol ... doorpkaipl. Europa. de pole beleilburheid, .

Siadsja1i .... vonlJ"1oopI de . zocIaI Ie de pede ceIIea aoolt be- de meatalf ..... _ pruduttiYileit Bethune, iD Konrijt belast ... ea- relkea. ... .. de IJewoItina. .. de leveos-tcme beIIekliqea. eoda' .. met '. Ia .991 stoolie bel .... op eea kwalitelt. .. . een IDleOtieverklariDI op at. Ie- leclmolOlie die bet .... Iijt....tt 0aanI0 IntenIalloaal kOlDt op tekend door de 39 .. juip AmeIi- moIecuJea ait Ie ~1eR zoader de resascbzoae naast de Kalak in Itause iDyesteenier Neil Gerardo. de"'re delen van hel weerse' Hooa KortrIjk. Die wil ia KOddjt eea tUniet wi ·lCbadetebelotteaea.Zo·nbebaa-. De poDdea zJja e1aendom van de pond ...... pell· ..... bakerpa- deli... II .. ciaIII' -_5.000 toI . de 51 .... De eersIe iopl.nlinl zal liIalCD ea saoposilieYea zicb zaI- .'.000 dol_ (rum. eea ... r miI- . DI.... aoderhaIve beclafe aroot len tunneD latea behaDdeleh. joea fraak) pel' padenl - eD belpl zijn. Gehoopl wonll dar de Ameri-

Gerardo inlematioaal leeeft...... . aileen .as de ziebe iD eeo vroe. . taaase mega·inyesterins hel effecl thuisbaYell ill DaytoDa BCIICb (Flo- .a.dia. wOldt 0IIldeb. van ceo economisebe SDeeUwbal ..... J eo $~'" I~~. ~~·'·.Le ..... kw II.... zale&elpbe ... taaIt YOGI'S 17 topvoners •• wel ail. . . .-de priv~- als de piablieke sector.' Vol.ens Luk ~basschere. die Het boekjaar 1993 went aflesJoIell. ill Kortrijt bet dossier 'opvolgcle,

--Bernard Vanc:raeynes' .

' .. -

. • •• • •••••••••••• ,. .' .................................. f •••••••••••••••••• f II •••••• f ••••••••••••••••••••••••••••••••••••••••••••

14/03 '94 14:22 e32 56 239003 STADHUIS KORTRYK

Dagbla~ :"Het Laatste Nieuws"

Amerikaans researchsprookje • KORTRUK

.. We wensen pen mosselen Ie roepen. vootaleer de boot aan walls.» Buraemecster Sans en heedt zlch voor euforie. Tech is bet met denkbeeldls, dat het stadlbatuur een stak medfsche toekomst near Kortrfjk kan ha­len.

Eind april wordt .duidelijk of een AmerikaaDs sprookje Jeans op sJasen heeft. Dan voen een del~atie van de groep .Gerar­do International» uit Daytona Beach (Florida) opnieuw be­sprekingen • .cDe agenda ver­meldt een eventueeJ conuact voor~ndaankoo~».zestSan. sen. «Ter voarbereldins van die oncierbaDde1ingeft warden in eJk geval reeds telesten venaald en atlerlei eJementen juridisch nagetrokkeJl», v~ Luk De­buSschere. medewerker van scbepen de Bethune, er aan toc. o. De verwachtingen zijn hooS­gespanllen. De 39-jarige ruen· man NeB GerardO wil op een terrein naast de Konrijlcse wi­veniteit, dat weldra «research­zane» als bestemmiDS krijgt, een onderzoeksafdeling cn een

bellandeJlnlP=ntrum \aapn. Bedoelin. JS om met befiulp van eon -ileD tecbnologie eon tbcrapie te ontwildceJen voor lcaDkerya.ti!nten en met bet Aids-VIM beamette personen.

o 'Oespreid over:rJaarwiJ het bedrijf. cia, ee ncijfer van 257 miljoen doUar ba8lt, 100 ~oen dollar (3.6 miJjardfr.) inves'ereft. lJl eel! eente tile zou 2.S miljoen doUar 8apen­deem worden aan de bOuw van een mediscb ceDU'IIDl met 7.000 m2 o~lakte. Om dit te rea­liseten wil .Oerardo Intema­tionabt l,5ba stadssronden aaakopea.

ArcbitecteD ~en reeds de pJarmen. Viffti. 'JOIICn lOU­den oit de VereDiacle StateD overkomen. de 450 andere werkDemers WOrdell let plaalSe serecruteerd.

De stratene liain. van Kortrijk bij KanaaItunnel en autcsnelweaen. de aanwezig· heid YID een univeniteit en de faciUteiren van een re~onaJe lucbthaven zijn troeven in het voordee1 van de Groeniap-stadt ..

«Gerardo Intenwionaai» heeft. het voorbije anderbalf jaar were1dwiid .prospectie ae· voerd. - PhoM:

-- - -------, \ ..

" •

~ \)J~ ~~ ~~~.,

4 ("0 I ~'l .

.., ~-

' .. ,.!. •... ,..... . ... : . ..;: .... ":

$FE

..

'-\e'

.- .. _ .. _----------...... ---Kulak h8eft vragen ;c.. I .

,. 1lI_~ • • .t, .. ' ~r I <-.

0/ 1/ 'Cf y; . . : I

! I

I

• I , I· I I I

J. :

I

\ ~ I

f

. ....

PU ~1AII1M1.8ZOll

DATUM/DA'lB : MARCH 5

rAX I

VAN/raO/tl/D, : LUG Debu •• aben ,.. I 32/51/2113 •• ~1 •• 32/51/213117

~AGINAS/PAQ.S:I (D.,' INB'GRB~.N/'l81S ON2 INCLUD'D)

BBBICH2'/M'SSAG'

DIL,

Mal"". ;JS. 1 '394 1.:': 13'3 .:.r1

1· CAlI IOU '0 .. A eo.! or III AIl~Ic:L8 I. II!ID •••••

2. on or .. 'IUOIII I. 1ft al'lfOD o. conaen II nLL COIII1II~D WIIB '1Oft.! J. !D PllUlCAClftlCAL IlIDUIsr I. 8a.oIUII ••••..•• BOUGH HUI J IIIAIt IIIA~ I • .. I~an. 'fIIBIR 18 ALUADI & fOIllalLIH to 08., u .. ,.ClfIQ euca !RIAtNIII ••••• .vI OILI AVA%LAILI POR VI.' •••••• A~ A co.~ or 1 MtLLlGI ••••• ~'" D.IClXP'fIO. or ~ ""'"'" ,. CCIIPLIIILI LID lID •••••• JI "'I • .rUDO IftllUlA'fIOllAL' •••• IP UI CU III 'V •• ' nIl 11POIMA~10R ••••• 1' ~ DID ~ou AIOVI l~'

INTERNATIONAL PHARMACEUTICAL COMPANY) (JI'''~ ;Lt~FS (THE SOURCE Gs: THE3CEO (DIRECTOR CENERAL) O(.~ ~:::.. ~;~~·N

LVC XXXX ELI LI LL Y XXXX c,. ~

SURVEY ON LOGISTICS IN EUROPE

Please use the enclosed return envelop or fax to (404) 894-6030

Neil Gerardo President Gerardo International 112 Water Turkey Court Daytona Beach, FL 32119\

IF ADDRESS IS INCORRECT, PLEASE INDICATE ABOVE.

TELEPHONE NUMBER: 904-756-1916

FAX NUMBER: 904-756-4~00

IF YOU ARE NOT THE APPROPRIATE PERSON TO COMPLETE THIS SURVEY, THE CORRECT INDIVIDUAL IS: NAME ............................................................. . TITLE ................................................................ .

NAME OF INDIVIDUAL RESPONSIBLE FOR INTERNATIONAL DEVELOPMENT:

·NEi·[ .. GERA·RDO .. ·· .. ····· .. · .. ···· .. · .. ·· .. ·· .. · ..

MAIN BUSINESS ACTIVITY:

·tw~T*l;;~t1~~~xW8~~'ffi=l~us IBACT ER I A &

·~8~~~a~\l~~~l~·~lr81~·~FFE·CTS AND WITH . EXPORT SALES AS PERCENTAGE OF SALES (Current):

0-5% 5-20% 20-50% (+50%)

MAIN EXPORT MARKETS (Current):

UK GERMANY FRANCE

( OTHER WESTERN EUROPE ) EASTERN EUROPE ASIA OTHER -CHINA & JAPAN •••••••••

EUROPEAN OPERATIONS (Current):

AGENT I DISTRIBUTOR SUBSIDIARY I BRANCH

SALES OFFICE DISTRIBUTION CENTER

* MANUFACTURING *R&D CENTER

OTHER NONE '.

DO YOU HAVE PLANS TO EXPAND IN EUROPE:

NOT IN THE FORESEEABLE FUTURE (YES: IMMEDIATELY ) YES: 1-2 YRS YES: + 2 YRS

IF YOU HAVE PLANS TO EXPAND IN EUROPE, WHAT TYPE OF OPERATIONS WOULD YOU CONSIDER: (Preferential order)

AGENT I DISTRIBUTOR JOINT VENTURE DIRECT SALES DISTRIBUTION

*MANUFACTURING *R&D

OTHER

IF YOU HAVE PLANS TO EXPAND I RESTRUCTURE LOGISTICS IN EUROPE, WHAT COUNTRIES (OR GROUP OF COUNTRIES) WOULD YOU CONSIDER: (Preferential order)

1 BENELUX

2 EASTERN EUROPE FRANCE GERMANY IRELAND ITALY

3 UK OTHER

IF YOU HAVE PLANS TO EXPAND IN EUROPE, INDICATE THE TYPE OF INVESTMENT YOU WOULD CONSIDER: (Preferential order)

*icEXPANSION OF EXISTING OPERATIONS . NEW DISTRIBUTION OPERATIONS

THIRD PARTY LOGISTICS SERVICES OTHER

CP~MENTS: ........ ~ .. ~.y.r.r.~~.t~.g.r.~m~.IJ~~ ... ~~~.~~~n the Rockefelle! .. bankmg .. grgup.,. .. Kissing.er..,: .. Zbigniew .. S.r.ilezi.nsk-i.~with..CMI.NA.-u.ndar. .. Operation .. e·ABl:ESPI;:I€·E·wifl"provide-·8'·sign i ficant "~·H~"pO't~nf·~()lY .. p~tltr(j""'''wlttr·a'M one Countr .. \ ...... a:········· .... ·········• .... ·l·········· .... ··· .. ·······'(r·t Y .J.O ..... Mr.9.p.~ .. g.r. .. 'n .... ~~~., ... ~ .. Mn'~~ ...... C. With the .. Eeder.a1 .. Reser.v.e .. oper.alingj .. th.e .. hea I th ca re system in the United States, it becomes apparer the scope of this competition with regards to any opposition from Europe. To compete on CHINA'S terms with computers at 1/4 the cost at higher capacities, superceding technologies will determine the degree of economic victory for each Country.

GERARDO INTERNATIONAL

NEIL GERARDO

PRESIDENT

31 MARCH 94 -- FAX TO:

.'

DEAR LUC:

112 WATER TURKEY COURT

DAYTONA BEACH. I"L 31119-8710

TELEPI-IONE (904) 7156-1916

LUC DEBUSSCHERE EXTERNAL RELATIONS DEPARTMENT CITY OF KORTRIJK 8500 KORTRIJ K, BELGI UM

FAX: 011-32-56-239003

IT IS INTERESTING TO NOTE THAT THE EFFORTS OF MR. E. DE BETHUNE AND YOU IN BRINGING THE MRX MEDICAL FACILITY TO KORTRIJK, BELGIUM; WILL PLAY A SIGNIFICANT PART IN THE REALIZATION OF PRIME MINISTER JEAN-LUC DEHAENE'S 3 PART ECONOMIC INITIATIVE OF INCREASING EMPLOYMENT, ENHANCING COMPETITIVENESS AND FINDING AN ALTERNATIVE WAY OF FINANCING THE SOCIAL SECURITY SYSTEM.

THE MOST IMPORTANT FACTOR IS THE ABILITY OF MRX TO RECAPITALIZE THE BELGIUM ECONOMY BY SHIFTING A PERCENTAGE OF THE WORLDIS CURRENT HEALTH CARE BUDGET INTO BELGIUM.

CURRENTLY, THE MRX TECHNOLOGY OFFERS THE ONLY CURATIVE THERAPY FOR NUMEROUS VIRAL DISEASES AND CANCERS.

TO CALCULATE THE ECONOMIC IMPACT IS A SIMPLE MATTER OF MATHEMATICS, THE 150 MRX MEDICAL UNITS WILL ATTRACT AS MANY AS 14,400 PATIENTS PER DAY FROM EVERY COUNTRY IN THE WORLD. RESULTING IN AN INFLUX OF FOREIGN CURRENCY DEPOSITS AT THE RATE OF $72 MILLION TO $216 MILLION U.S. PER DAY INTO THE BELGIUM BANKING SYSTEM.

THE BELGIUM ECONOMY CAN EXPECT A GREAT INFLUX OF AMERICAN DOLlARS, CREATINGAMULTITUDE OF NEW JOBS~r EVERY PAY LEVEL: AS THE GRADUAL SHIFT OF APPROXIMATELY ONE TENTH ( $95.5 BILLION U.S.) OF THE $1.2 TRILLION U.S. HEALTH CARE EXPENDITURES ARE REDIRECTED INTO BELGIUM.

WE AT GERARDO INTERNATIONAL APPLAUD THE RARE QUALITIES DISPLAYED BY MR. E. DE BETHUNE AND LUC DEBUSSCHERE IN THEIR ABILITY TO FULLY COMPREHEND, GRASP AND REALIZE THE MRX TECHNOLOGIES CONTRIBUTION TO GLOBAL HEALTH AND ECONOMICS ·AND ITIS ROLE IN BRINGING PRIME MINISTER JEAN-LUC DEHAENEIS vlslq~ TO REALITY.

GERARDO INTERNATIONAL 112 WATER TURKEY COURT· DAYTONA BEACH, FL 321 19-8710

TELEPHONE (904) 756-1916 •••••••••

MRX

A radiosurgical procedure based on absorption achieving molecular specificity for in vivo elimination.

MRX is an innovative Nuclear Medical Approach derived from technologies with foundations in Medicine, Radiological Physics, Electronic Defense, Electronic Intelligence and one technological facet of SOL

MRX is unique in that it is the only procedure that will not cause mutations; unlike organic and bio­medical procedures which produce new resistantstrains. (No virus has ever been eliminated in the history of man -cold-flu-herpes- due to their continual mutations requiring new vaccines every year.) MRX provides humanity with many of the solutions beyond the limits of organic chemistry (drugs, gene therapy, etc.)

Because MRX is best defined as the ability to remotely detect and break down specifically targeted molecules into harmless and helpful lesser substances within the human body; it will not adversely effect healthy tissue.

The impact of MRX with its $5,000.00 procedural cost results in the saving oflives, reducing health care costs, increases the profitability of insurance companies, lowers insurance rates through increased amortization and reduces ineffective government spending.

Distinguished targets include. but are not limited to:

HIV

BREAST CANCER

OVARIAN CANCER

HERPES 1 & 2

PROSTATE CANCER

C 12 August 91 • Gerardo Internatio nal, Daytona Beach, Florida 32119. All Rights Reserved. Gerardo Intemalion.ill is so~ responsible for its conlent. MRX is thc valuable property of Ceranio International; containing technologies covered by Presidential O rders and a multitude of Classined Technologies requiringlicc:lse ,lnd dulhoril ,lt ion from one of more United Stales GovernmenlAgencies and Departments. Any use. storage or Iransference of any aspectof MRX Is strictly forbidden. All "spect~ of .... 1I~ X arc governed by and construed in accordance with Gerardo International's Confidentiality Agreement; which must be executed prior 10 any transference. storage, u ~e or impteillentation in any degree; including. but not limited to the expressed and implied information and applicalions contained in this non<ompromiscd abridged ,lb5Ir,ICI.

DUPLICATION & DISTRIBUTION OF THIS DOCUMENT IS AUTHORIZED AS OF 1 SEPTEMBER 91

PATENT STATUS: APPLICATIONS FOR ALL CLAIMS BEING FILED

Over 3000 tests have confirmed that in every test. without exception. the targeted molecula (Breast Cancer, Ovarian Cancer, HIV. Herpes. etc ....... ) was completely destroyed wirtlolJt any harm to healthy mol· ecules.

Gerardo Intemational • originally formed as a high level think tank. is a network of 517 former government and private sector SCientists of diverse and multiple disciplines possessing documented scientific accom· pllshments of precedent setting signi'i· cance . Many hold multiple Ph .D·s and M.O·s.

There is absolutely no connection between MRX (discovered on May 22 . 1991) and U.S. Health Trust (discovered in February 1989). MRX is a scientific discov­ery and U.S. Health Trust Is an economical­ly proven financial funding model for the health care system.

The charts on the last few pages are an extreme simplification of MRX. In this exam­ple two different molecules are mixed togeth­er, the first is a solvent, cyclohexane, the sec· and water and the mixture is bombarded with an infrared laser light beam tuned to the car. bon - carbon bond. All molecules above -454 F vibrate around their bonds with the frequen· cy of vibrations being dffferent for each mol&­cule. If a pulse of energy of the proper wave­length is shot at a C-C bond. the bond will absorb the energy by increasing its vibration. When the energy pulse stops. the C-C bond will rtrrelease this energy and the vibration dampens or slows. If the beam is continued the C-C bond will continue to vibrate at an increased rate. If the intensity of the beam increases, the C-C vibration will increase. If we continue to increase the laser energy we will reach a point where the vibrationaJ ener· gy will be greater than the bond energy. the bond breaks, th e molecule is shattered. Since the wavelength of the laser is tuned to that C-C bond, neighboring molecules will be unaffected. This is similar to how sound waves can shatter a crystal glass but the room remains unaffected.

In the simplified example we have water and cyclohexane in a glass beaker. SItting next to the beaker is a tunable infrared laser and sensors (ears). The wavelength for the water (H-O bonds) is about 2.7 microns and 6.75 microns. We will avoid these wav&­lengths. The wavelength for the C-H bond in cyclohexane are 11 .1 microns and we will avoid this with out laser. We will tune the laser to the C·C bond cyclohexane which ""' between 6·7 microns. This wavelength is unique for this molecule, It Is part of irs ~n­gerprint" which is completely different from other C-C bonds.

In step one. A low energy beam enters the sample while the sensor listens for the C-C resonance. The beam wavelength is varied slightly until the C·C bond resonates. this step is called ·coupling". This is similar to tuning a musical instrument using an elec· tronlc tuner.

In step two, The coupling of the laser wavelength has been coupled to the e.e bond wavelength. The C-H and O-H bonds are unaffected since they are and completely different wavelengths. We then increase the laser intensity which increases the c-e vibra. tlon and the sensors continue to monitor the "lock" or coupling.

In step three, The intenSity has passed what is called the Schottky barrier and the C.C bonds break. The laser continues to Insure the C-C bonds do not reform. The empty bond snes are then fillad with avai~ able atoms, usually hydrogen since the laser Is still running, preventing reformation of C-C bonds.

In step four, The laser beam energy is reduced while the sensors continue to ·/ls· ten" to verify no cyclohexane IS present. The beam is shut down and we are left with water and methane. The entire process accrues In a time frame of nanoseconds (10-.) to milliseconds (10-,).

This is an extreme simplification of how MRX works but is sufficient to give people an insight into how we can target and eliminate specific molecules, organisms and cells.

The science of emmision and absorption spectroscopy has existed for over 140 years and it has been common knowledge in this field that every atom, molecule, virus, cell, etc., has a unique absorption spectrum (fingerprint). This has been used for remote senSing in astronomy, physics, chemistry, medicine, geology, and other scientific fields for over a half century. The MRX technology merely takes this science to a new level. Instead of using absorption spectroscopy for just detection, we use it to actively control, manipulate, modify. or destroy material on a molecular and cellular level.

GERARDO I'!'1TERNATIONAL liZ WA TCR TI.,J R K C Y COURT

OAyTONA BCACH . ' L 32t1g-e7 10

Std 1.

.$frr 3.

Sensor

5 ef\l,J~

~

~~ (

C.vfl;.~

~",f:r"""t.o.I"'"

S .",,,,r

Qt:= ~

" H / 'ft

\It" \1

C A ?, ,/..,,\. /" C 4( C

It""' (' row

I\C

lhc..

0 ~ !<. H/

H- c l' /c-H

t:"H/~} \';0 H 1\

- -c-c ,,·.'D< ... t ..... \"'CrCASI"'~

C-H 0-1-1

c:. 1-11-

,t

~ 1 'H~

c-c C-rl

o -H

uflo.ff"c.t • .l "" o.Tfeo<teJ

,?! 'Hz. H/

" C liz.

'oOI\~> rUf-\"rc. b." a ... t,,< t Po",J ·''1t .. ,"

"II

0 'Ii

CHl. p~,l< vf \)J ... ter r~"'''·''.s

v.., .. {( e't.~ ~r • .., 1-1 "te . .." i~ f :11

GERARDO INTERNATIONAL liZ WATr::R TURICCY COUIIIT

OAYTON. _CACM ,.\. ,3ZIIV-e710

J 0 " I"t",,;.T; !Vlcre.~

, \ " ~

t

\ \ cuCf

• 15474·1 CAS [11lJ.82-7] C~cloh.x.ne. 99 + 0/.

u .. . • .. ..... - " '- - '--r--1M

- -- •

.. - -.- .

• U .L. _ • .. .. J

FW84.16 mp6.5OC lip 60.7-81 OC 11-

dO.779 Fp·1°F nil 1.4260

.. _ ... L ._ .. _'t ..... t .. . ... .... . r. ._ .. i _. __ ........ -._ . ..... . -.. .. _._._ ... _-_ ... .. ~=,

IR 111,250 Merck 10,2717

. .. . ' ' • • t . .•.. ',' '.2 ',2

• .. -.... -.. -.- _ ...... '" - .-- .:.- .--i- . : . -r , "; -.-.-----.- .... .. , -_ ._ .. _ . _ .. - ... . _ - _.- .. -. " . ., ... StltJlChlng · BsndIng , . ' • .•• .• . 0"

n ~ ...• _.~. _._ .. ________ . ~-:--.;. "'! _ ...... _ _ _ ._. _ _ ••.•....••• • _'_' .' __ "_' __ ' _ _ · ~ ~ ", . . ... _. ~- _ -.~ '. -.: -~ ,.' ::.:.:.::..:: : ~: I. · ~~ - .- . . ...... _- . __ ....... -._---,

1 •• -· ~ ... -­~ :.;.

", __ , _ _ •• __ _ _____ . _ •• • 0 ••• __ _ •• __ •• __ •

" ' NEAT • __ ... . . ... __ ... ..:~: ....: _~ _._._. _. :C-H.-.j,rkrh M._~ . __ .•. __ __ .. _ ... _ '"

. . srrolcNng

, .. - ---. ,,- - --. - ---.- c.c aboolptiOn

C-H absolptiOn ._ . • . _._ . . ___ _ Bending

- - J _. _ ..

--J

• ._,,' . - " _ .. " ..... _ _ _ .. :_._. __ .. _.1.. .- ._1 _ _ ._. ___ _ .. _ _ .. _ "". __ . " . .. " .. __ " .. .1 .. --. _._.1_. _._ ------------- .... - 1_ ,_ tIICI

w.a"...,.. .... ..

.. ',' ',' . , .

2926.7 1256.9 2659.9 903.3 1449.9 661 .5

17 II II 21 '" .. ' . , , , I I • I '-Q..,

-cu

-o~

-u -u -... -o.T

:U -u .. -NICOLET 20SX FHR

MRX's COUPLED LASER TUNED TO THIS WAVELENGTH ONLY.

THE MRX TECHNOLOGY

THE DETECTION AND THE ERADICATION Of THE AIDS YIRUS

MOLECULAR SIGNATURE ANALYSIS AND ANNIHILATION

A remote, intra vivo, non-invasive and non-deleterioul method of Molecular Signature Analysis and Annihilation.

Real nme Zero Window Detection and Eradication exhibiting specifidty and accuracy suffident to confine annihilation

to an anomalous single molecule or mass without affecting contiguous salubrious molecules.

Applications include. but are not limited to

the AIDS VIRUS (HIV) AND NUMEROUS fORMS Of CANCER •

. . The MRX Technology is a

NEW METHOD Of DETECTING & pESTROYING SPECifiC UNWANTEP CELLS. ViRUS & BACTERIA AT !HE MOLECULAR LEVEL WITHIN THE HUMAN BODY ANP WITHOUT HARMFUL SIDE EfFECTS.

Using a combination of several underlying technologies including Nuclear Magnetic Resonance (NMR) and X-Ray Laser Spectroscopy; this device is able to detect and distinguish the "Spectral Signature" which acts as a unique fingerprint specific only to that particular molecule/molecules to be destroyed.

After targeting the specific unwanted molecules; sufficient energy is absorbed directly and only into the molecules needed to be destroyed. This energy vibrates the molecular bonds between the atoms until they break apart ••• rendering the unwanted cells, virus or bacteria harmless.

IIMRX Technology & the Eradication of the AIDS Virus"

The Science of Spectroscopy, or the interaction of electromagnetic radiation with molecules, has been an intense field of study for over a century. Molecules have the inherent ability to absorb specific wavelengths (frequencies) of energy and re-emit them giving the molecule a unique spectral fingerprint, each with its own characteristic absorption/emission lines. When this energy is absorbed, it creates a rotational and/or vibrational excitation about its molecular bonds. A molecule with "N- number of atoms possesses 3N.6 or 3N-5 degrees of vibrational freedom throughout the EM spectrum. The advent oflasers gave man the ability to induce coherent energy at one specific frequency into the molecule. Gerardo International in Daytona Beach, Aorida recognized that this technology could be utilized to detect and annihilate viruses. By pre-energizing the molecule with nuclear magnetic resonance energy and further exciting specific bonds corresponding to its own specific spectral absorption peaks, we found that sufficient energy could be coupled into the targeted molecule to induce breaks in numerous molecular bonds, therefore shattering the virus. By using multiple energy sources, corresponding to HIV's Spectral fingerprint, adjoining healthy tissue remain intact .. 1)1is is analogous to sound waves shattering kidney stones without shattering the kidney or any other surrounding tissue. Gerardo . International merely recognized that by combining this pr~ existing knowledge, we were able to pioneer a definitive solution to the AIDS Epidemic. Current indications project the cost at $5,000. (with no further treatment necessary.)

AN INTRODUCTION TO MRX

MRX is an ambitious undertaking whose genesis was a bastard offspring. While engaged in research significantly removed from MRX current trajectory, certain fortunate anomalies in an experiment were noted. These anomalies have become the framework about which MRX has grown.

One may describe MRX as a magic bullet composed solely of energy, whose application is molecular marksmanship. What one has here is a powerful tool for analysis, diagnosis, and mitigation. Dealing selectively on an intracoporeal or extracoporeallevel, biomedical technology fhially has the ability to specifically identify, quantify, and treat various diseases. Since MRX operates on a fundamentally molecular level, many varieties of disease and/or infection fall within the scope of its function.

In order to understand how MRX operates one must proceed through a thorough study of quantum physics. However, by analogy and example herein contained, certain elucidation as to the functioning and concept may be realized. Furthermore, effort, application, exploitation, technological spinoffs, and industrial economic ramifications will be examined in due course.

The initial step in explaining any innovative technology is to lay a firm foundation in established, precise, and accepted science. Once this foundation is firmly established, all departures and expansions on the base technology need to follow prudent syllogisms without indulging in abstract nomenclature or idiomatic representations. However, in order to present the ideas .~nd concepts of the indepth science encompassed by MRX without the obfuscating nomenclature, certain liberties need to be taken.

Where necessary, analogies will be used to illustrate function. By definition, analogies serve well to illustrate. However, one needs to recognize that analogies are also a departure from the best factural representation.

MRX is a technology based on pure quantum treatment of lattice energy transfer mechanics within macro molecules. In less technicalese; one might suggest that rather than trying to sift for a variety of specifying attributes, MRX images the interrelationship in total of a complex system. Much like a hologram is composed of the interference patterns resulting from multiple sources of information, MRX is an image resulting from the summed perturbal spatial and temporal characteristics of a molecule. Also, just as a Hologram, when properly illuminated, can synthetically represent the original "analysed" object lambertian image plane, MRX can use a synthesized spatial energy distribution to stimulate spontaneous coupling and subsequent relaxation emission. The key to understanding the mechanism under which MRX operates resides in the energy transfer mechanics within the molecule itself.

In simple molecules or individual atoms the energy within the system is shared through a relatively basic artifice. Fundamentally, energy is stored in inertial packets called quanta. These specific units of energy are easily contained and moved about by subatomic particles called electrons. This rudimentary system is by itself responsible for most of the observed day to day interactions that by which we exist, define time, and conceptualize space. However, slightly more esoteric is the higher order energy transfer and conversion systems resulting from the fine, hyperfine, and lattice structure that forms the framework for matter and energy. Some of these energy systems (it is acceptable at this level to consider energy and matter entirely equal) deal with nuclear instabilities. Insofar as MRX is concerned we can ignore all the energy tied up in the nudeus except for the inertial affects of the nucleus as a bound system. Remember, MRX deals with the interaction of atoms not with individual atoms themselves. MRX is primarily concerned with a quantum system resulting from three distinct molecular/atomic energy transfer mechanisms. The nomendature generic to the field calls these three quanta carrying sprites "Phonons, Vibrons, and Plasmons".

Imagine a single instrument playing a melody. If played well a selection conveys several pieces of data. lnitially, it is the tonal qualities of the instrument (for the moment ignore the skills of the player). This primacy in the temporal stream may convey to the astute listener the instrument variety and pitch. As time continues certain other tidbits of information become apparent. The major key becomes established, the tempo, and finally the melody emerges. If one adds several other instruments of the same and complimentary varieties, interesting eventS take place. Playing the same melody and in the same key, the overall harmonious cacophony develops a unique persona relative to the blending of the constituent instruments. The operative term here is IIblending". In affect the blending still is orders of magnitude more complex in information/data then the primary melody line itself or the individual intonations. Clearly, aside from the melody line there exists an interdependence of interactions resulting from many conditions not the least being the spatial separation between the instruments. (It is assumed that the instruments can be in perfect tune and the skill of the musicians is without flaw.) This presents a close analogy for the mechanism within the molecule that MRX is imaging.

Rather than listening to a temporal melody played by a single atom, MRX listens to the interaction patterns that occur in toto. It is the energy mobility between the plasmons, phonons, and vibrons that give rise to the specific harmony of the molecule. This harmony is uniquely specific to an exact molecular constitution and geometric arrangement.

Normally this lattice energy interaction is a lesser preferred device within the molecule. It is a signal that takes a back seat to the grand melody played out by the gross movement of vibrating atoms and cavorting electrons. Nonetheless, it is present and has a possible enhancement personality. By creating certain operating constraints on the overall molecular system, the interaction sequences may be enhanced well over a million fold. By developing a synthesized signal, energycan be directly coupled to the system. Much like an opera singer can cause a crystal goblet to resonate and subsequently shatter, so can enhanced coupling pump significant energies into an atomic lattice.

All this is well and good for demonstrating how the energy is coupled and stored within the lattice, however the question remains: How does MRX utilize this phenomenal To answer this question, again a tool of favorite character, the analogy, is utilized. Picture a large gathering. Imagine that there exists a great multitude of diverse individuals, congregated together, all wearing the same clothing. It is easy to recognize that some are different; some are taller, some are fatter, some are of various races. However, in order to glean the location of a single individual, these traits only serve to reduce the overall population. It is an elimination game whose results are far from perfect. Statistically this is the appropriate technique. Eliminate other populations and probability will increase that your individual will reside within the remaining group. Closer examination will yield data regarding the sex, age range, and eye color. These delimiters still do not definitively help select the individual sought In essence this becomes aldn to a filtering process. More efficient would be the scenario played if one would employ a parametric probe. A most efficadous technique would involve addressing the congregation over the public address system with certain inquiries. Rrst, the inquiry would be to ask an individual with a certain first name to identify themselves by raising their hand. (Assume that this is a convention of truth tellers and that none would purposely commit the subterfuge of lying). If the name was unique, perhaps the response would be singular and thus would end the experiment But possibly, the name was more ubiquitous than not. This being the case several responses would be forthcoming. Now, the inquiry would be for those with that first name and a specified surname. A further delimiter might include the occupation, address, and possibly the spouses name. With this data one would be assured that the individual responding is the one sought.

MRX in essence proceeds in the same manner. By utilizing a signature (read energy in specified temporal and spatial images) a relaxation response form coupled molecules is accomplished. In essence it is akin to the person in the gathering raising his hand and calling out IIHer I Am". The technology encompassed within MRX utilizes this premise to create the scenario herein analogized. Furthermore certain further perturbations are realized. With highly efficient coupling, energy levels in the molecule can be increased until the point of catastrophic failure of the molecule occurs. Once failure occurs coupling ceases as the molecule no longer possesses the initial resonant coupling characteristics. Just as the opera singer caused the crystal goblet to shatter, so too may the flux of energy coupled to the lattice, if increased to a critical level, eventually cause its failure.

Engineering is the final obstacle to the completion of MRX. The sdence is sound, the technology available, and the need explicit A considerable effort is necessary to bring the diverse engineering disciplines together to achieve the gestalt science necessary for the completion of MRX. from these disciplines various ancillary applications will likely become apparent. Obviously the initial utilization of MRX would be for the detection of specific viral infections. However, with the proper biomedical expertise a whole catalog of diseases, that are tagged by specific molecular arrangements, may be addressed. This would include any disease that has a DNA or RNA progenitor. Some cancers, systemic infections, and parasites would be the first order of thought. Also tagging and enervating certain molecules for genetic surgery seems highly likely. Truly, MRX is a potential boon to the medical community and all organic scientists. Since the operational wavelengths over which MRX operates is in the X-Ray regime, intracoperal and invitro operation is just as efficacious. Furthermore, intercellular operation is of no consequence as it is for most vector approaches.

Such a tool, in the industrial community, would give rise to technology for growing perfect crystals. creating paracrystals, molecular analogs, and new dimers.ln addition it would be an analytical instrument for a whole variety of applications. MRX from a technological vantage will produce a cornucopia of spin off applications.

As further study of molecular sdence continues, it is possible that MRX will provide a fundamental insight to submolecular species. This would only occur if and when techniques for imaging energies in the gamma r av regime become available.

for a variety of reasons, (called economics) certain organizations would not enjoy the completion of MRX Likely naysayers would include pharmaceutical concerns, medical organizations, and those with a status quo political .1genda. When MRX becomes operational, many of the aforementioned groups will stand to lose a great deal of income a nd power. Since MRX treats diseases that affect the most fit and active (socially, sexually, physically, etc.) members of SOClt'1'\ L ertain questions are likely to present themselves. i.e. Who will share the economic burden of the health care system , .. npn the chronically ill and elderly (read; inability to pay) become the super users of the system. Clearly MRX is a pOlilt .11 more than a social issue. MRX will reverse the current health care crisis; economically and qualitatively.

Please regard the preceding as a lay approach to very complex issues.

EXECUTIVE BRIEFING Current techniques for diagnosing viral infections rely on a sampling of a possibly insignificant portion of viable tissue

(this would include blood and blood products). Generally, the course of an infection does not start systemically. Rather, the infection is received through a very small nexus at the point of contact with the infectious agent or carrier. State of the art detection methods use antibody tests and personal histories to soeen probable Asymptomatic Infectious Agents (AlA). By the time a virus has entered the stage at which the bodies immune system is reacting to its presence, it may have already been intracoporeal for a period well in excess of 90 days. In isolated cases where there has been a massive infusion of the contagion, earlier immune reaction response may be initiated. Also, as stated earlier, if the infection is introduced in either a weakened state or in a very small quantity, the "incubation period" is severely extended. Recent studies indicate this lIincubation period" may extend to and beyond 10 years.

Viruses are different from general floral infections one is more familiar with. While bacteria, parasites and symbiotes are capable of thriving and multiplying within the enveloped environment of the corpus, viruses and their more primitive relations, prionsj are not so adept These most simple bits of primitive organic compositions are not very much more than isolated involuted strands of genetic material (deoxyribonuvleic add, more commonly known as ilONA"). As such they are without possession of any attributes assigned as our criteria for viable life. If anythin& they would be constituent parts of a living entity. It is partially a paradox, because even though these very pervasive agents are present bane to human kind, they are responsible for all known life. It seems that early in the evolutionary cycle, certain prions were incorporated into the permanent makeup of some single celled creatures. These prions became permanent structures indispensable for the more complex functions necessary for life. Mitochondria, the "powerhouse" of the cell, produce almost all the energy needed by the cell to function and replicate. Lyceums, nucleoli and golgi bodies are all further examples of an incorporative process. It is theorized that these individual organelles are in effect viruses or prions associated into a structure by which the organization provides a host environment Incorporated Viral Components "IVC's) thus form the componentry for the most diversely complicated and organized structures in the universe, living matter.

Ancillary reasoning for the formation of life would be the existence of such primitive structures as prions, for without life these normally inactive agents would serve no function. They would not be able to reproduce, feed, grow, thing or bear any attributes resembling viability. However, when they are matrixed with a living system of cellular derivation, they are intrinsic catalyzers and parasites. They now reproduce, feed and mutate. While this does not meet our criteria for life, it does signify a close interaction with living structures. Truly happenstance may predict the possible permutations by which these organic structure came into existence. However, once they are present, life itself becomes a progression of the recombinant perturbations.

This very close alliance with living systems identifies the main significant problem with ascertaining the presence andor eliminating the presence of them from otherwise healthy somatic tissue. Chemically they are identical to the very identity of live itself, the genetic code. Within the cell, RNA (ribonucleic acid) is found in the nucleoli (IVC). These round bodies drift within the Nucleus, making essential proteins and being cannibalized fo~ RNA during repair of DNA and reproduction of the cell itself. This is where the problem lies. The Nucleus is designed to sue available genetic material for these repairs and during Mitosis (cellular replication) and Meiosis (gamatic DNA formation). When the Nucleus is "contaminated" by a virus stripped of its protein shell (as in the case of HIV) it is unable to recognize it as being foreign. It is used as unjudiciously as any other available RNA. Inserted onto the chromosomal strands when they unzipper during reproduction, they are replicated along with the balance of the genetic material. They now have accomplished that which they were unable to achieve by themselves. Realize that this is not an attack as with bacteria. The genetic material is, by analogy, invited along for the ride at the insistence of the host cell and not by any inherent infectious nature.

In order to exist outside the Nudeus, the virus needs a protective jacket This is the one function that the virus can accomplish. It produces a protein coat that intrinsically protects its relatively fragile genetic makeup. It produces this coat not be secretion as with living systems, but rather by accretion. Gathering chemicals from its immediate environment, the virus insulates itself against attack from naturally occurring decomposition reagents or enzymes. This protein jacket is the very flag the body uses to identify the virus as an invader. It can differentiate the virus as easily as identifying a bright red dress amidst a room filled with women in all white satin gowns. The body then.oeates specific antibodies to attack the invading virus. This is also the technique by which one may diagnose an infection. Identifying the presence of antibodies with the proper protein IIkey" to fit the protein coat on the virus provides a positive test result Even if the individual is asymptomatic, it is an assumption within reason that an exposure to the virus has taken place.

Several factors contradict the accuracy of the antibody testing. (1) a statistically healthy survey is required to assure an appropriate match. (2) it can only be assumed that the immune system is currently responding to the infection systemically. (3) a healthy immune response mechanism can only be assumed (4) it must also be assumed that the infection has been incubated somatically for a period of time sufficient to attract the attention of the body's defenses. These factors specifically identify the potential areas for remiss. Others also may be of significance, but are addressed and resolved by conventional solutions.

In addition to the protein jacket there are additional flags for the contagion (read "virus"). While I have stated that the chemical makeup of the virus is identical to that contained in the normal genetic material, one shOUld not infer that the virus is wholly equal to regular genetic material. DNA encoding is accomplished by sequencing. Just as all written

, languages are compilation of relatively few vowels and consonants, RNA and DNA are composed of only 6 respective components. It differs from DNA in only 2 primary ways. The sugar in RNA is Ribose, and RNA contains the base Uracil, instead of Thymine. These differences are because of the stitching bonds that form the distinctively well known double helix. If the body could "read" the pattern for the specific virus and recognize it as being a virus the body would have no difficulty in responding effectively enough to prevent any transfer of genetic material. However, at this juncture, evolution has let us down. The same versatility that provided an environment for evolution through IVC has now allowed for a continual process of DNA contamination through viral contamination. Effectively the virus is carried with the TRNA (transfer RNA) as it would any conventional assembly of genetic material.

Technology does present several solutions. With atomic microscopes, one can precisely topographically map the exterior of the offending virus. Chemical stochionmetry can be precisely ascertained through NMR (Nudear Magnetic Resonance) assay, Mass spectroscopy and chemical tagging. Genetic sequencing can be accomplished through Vectors (genetically engineered viruses) and through conventional gene sequencers. The data resulting from these tests present the scientist with a virtual Rosetta Stone for identifying and elucidating the unique characteristics specific and individual to the Virus.

In the case of HIV, all the previous described data has already been established with a high degree of certainty. This virus is small, relatively simple and as conventional as one could expect it to be. This is why its catalyzing actions within the body are so insidious. It progresses very slowly and does not cause the body to respond in a girding of all defenses. Generally the body is wholly unaware of its presence for 60 to 90 days. When the body does respond, it does so in a half­hearted fashion, since the contagion is so easily destroyed and does not affect contiguous structures with its presence. However, the virus, by acting so slowly and most actively on actively reproducing cells, very gradually diminishes the viability of the immune system. No one has ever died of the infection of HIV. Rather, they die of "opportunistic infections" caused by the body's being so gradually weakened during the course of the infection. If the virus were more damaging, as to cause intrinsic symptomology of the virus itself, the body would easily suppress it However, the immune system does not recognize the virus as a major threat to its viability.

With technology, one can apply sentiment reasoning to the cause and affect of the virus's method of operation. Current efforts with "Vectors" should prove excellent in procuring a cure for the infection. However, early detection has been elusive to past methods and approaches in resolving the problem and identifying a cure. A doser inspection of the previously assembled knowledge of HIV reveals that a solution does indeed present itself for recognition. Once the mass, structure, composition and arrangement of the virus is precisely ascertained (already confirmed); it becomes increasingly obvious that an extension of physics is available to facilitate scanning of the HIV virus. The scanning apparatus is a combination of proven technologies, induding the X-Ray Laser and the discipline of Nudear Magnetic Resonance.

A single sample of the virus can be scanned using thi~ technology to determine virtually all properties. To proceed with a ZERO WINDOW REAL TIME DIRECT VIRAL ANALYSIS; the following criteria are easily accomplished; (1) Diagnosis must take place in living tissue (intr vivo) (2) Diagnosis must not be through invasive or deleterious action. (3) The diagnosis must be absolute. (4) The diagnosis must be accomplished in Real Time. (5) The diagnosis must specify and quantify the location of the virus. (6) The diagnosis must be available ubiquitously. (7) The diagnosis must resolve all aspects of the exposure question.

Physical science indicate certain actions available to all matter. These activities indude mechanical, electrical, magnetic and specific quantum effects. Science can with great certainty, predict each behavior given a known atomic and molecular configuration and composition. The configuration and composition of the HI virus is precisely available. With this knowledge, we have assembled the proper technologies to scan for its presence. A few of the specific properties we analyze are inertia, harmonics, moments, resonance, precession, absorption, surface plasmon scattering and Raman spectra.

With a Laser tuned to near resonance with the virus, a certain degree of coupling is accomplished. When the virus is placed in a magneticfleld, itwill harmonically generate a "signature" Raman shift. This spectra of 1250 to 1540 angstroms shows up as hai'ri1onic banding at evenly spaced quantum intervals. With spatial filtering provided by the molecules (read "virus") with plasmon scattering in the 16 - 40 angstrom range; a quantum detector will accurately signify a positive or negative reading. Through source scanning and measurement of the scattering angle, a reading of the proliferation and precise mapping of the exact location is accomplished. PRECISION TO ONE MOLECULE IS REALIZED. Real time zero window signal processing achieves positive or negative verification.

It now becomes apparent that the technologies are already in place to couple a larger, more significant energy level directly into the molecule. When sufficient energy is coupled, the molecule is not able to shed the energy fast enough to avoid overcoming a quantum electrical property known as a Schottky barrier. This causes a breaking of one or more bonds; RENDERING THE MOLECULE NO LONGER VIABLE AS A VIRUS. AT THIS POINT IN PROCEDURE, THE PATIENT, LIVING TISSUE, TRANSPLANT OR BLOOD TRANSFUSION IS VIRTUALLY (100%) ASSURED FREE OF INFECTION. NOT ONE MOLECULE WILL REMAIN TO INITIATE A RE-OCCURRENCE.

THE DETECTION AND ERADICATION OF THE AIDS VIRUS CAN NOW BE REALIZED. MRX REPRESENTS A QUANTUM ACCELERA TlON IN THEABILl1YTO MANIPULA TE MOLECULES AND WILL IMPART FAR REACHING EFFECTS WE /-lAVE ONLY BEGUN TO EXPLORE. THE APPLICATIONS IN MEDICINE, INDUSTRY AND DEFENSE PROPELS SCIENCE TO A NEW PLATEAU.

TECHNICAL BRIEFING

MRX incorporates a quantum process described as a non-linear relaxation osdllation scattering. By relaxation, it is understood that the phenomenon refers to the events that during a given exdtation phase an observable interlude elapses between the moments when a system in equilibrium is subjected to a momentary change in condition and the moment when the system is again in equilibrium.

An analogous system of simple showing relaxation is an uncharged capadtor with a capadtance C connected in series with a resistance R, to which circuit a constant voltage U is applied at a time t+O. The charge Q of the capacitor at time t is given by the differential equation .•. U - Q/C + R dQldt Offering the solution Q - CU(l-e -tlRC).

The charge Q does not follow the sudden change of U, but shows an exponential increase towards the final value cu. The time tau-RC is referred to as the relaxation of the system. The sum tau governs both the rate of charging and the rate of discharge; if the capacitor with a charge Qo is short drcuited via a resistance at the time t-O, then the charge at time t is given by the single exponential equation QIIIQo*e -tlr. Multi-exponential behavior of the type y-ao+N sigma n-1 a(n) e -t/tau{n) is found in the instance when the time dependence of a system is not described byeq 1, but by instead a set of ~. coupled linear differential equation.

Analogous systems of relaxation are treated similarly in various diverse areas.

(1) When a spring is connected to a receptacle and is restricted to a single order moment, is instantaneously loaded with a constant force, it will take some time until the system is again in eqUilibrium.

(2) When an electrically or magnetically polarized substance is suddenly placed in a constant electric or magnetic field, it will take some time until the electric or magnetic dipoles have oriented themselves.

(3) If the irradiation of a phosphorescent substance is suddenly stopped, the phosphorescence does not cease immediately, but continues for some time during which the intensity deaeases exponentially.

On behalf of the procesSional motion, the magnetic moment has not only a longitudinal component in the direction of the new magnetic field, but also a transverse component at right angles to the new magnetic field. Wheras it would seem logical to expect that the longitudinal component would increase and the transverse should decrease exponentially with the relaxation time due to the relaxation mechanism, in reality, this is not so.

Experiments have shown the transverse component decreases faster than the increase of the longitudinal so that apart from the longitudinal relaxation time, there must also be a separate transverse relaxation time which invariable is smaller than or equal to twice the longitudinal relaxation time. The existence of a separate transverse relaxation time besides the longitudinal one can be explained by the fact that apart from the return of the individual magnetic moments of the nuclei to the direction of the magnetic field, (Which is characterized by the longitudinal relaxation time), it is also possible for these individual magnetic moments to continue their precessional motion along the same conical shell though receiving phasal distortions because of mutual interactions. In the latter case, the longitudinal precessional moment remains unchanged.

Just as with non-resonating systems, periodically changing quantities can be successfully introduced in resonating systems; in the case of a substance containing magnetic nudei, this is accomplished by applying a stationary magnetic field Hz in the z· direction and a 2H1 sin omega t in the x~irection. This is known as a nudear magnetic resonance event. In this case, a periodically changing magnetization intensity is created in the x~irection whose real (in phase, dispersion) component M' and imaginary (out of phase, absorption) MN are related by a third order tensor equality.

When through an increase of the magnetic field intensity, a broadening of the cross over plateau of equality between M' and M N

, a spatial resonan~ c;ondition occurs. At this point absorption becomes 0 throughout an non-linear dispersion becomes the exclusive condition. This phenomena is called saturation. It is possible to calculate in principle from curves plotted for different known values of the periodically variable magnetic field. In practice, pulse techniques are used, often combined with Fourier transformations. Both relaxation times are very much dependent on temperature and frequency and on the phase of the substance under observation.

While the relaxation times are critical to determine resonance conditions oscillation loading and needed field density, they are not significant for macro molecular signatures. They do in fact provide critical insight in determining the conditions for producing non-linear surface interactions for the gross molecule. In essence, the creation of a highly mobile system of interacting surface plasmons and phonons. It is the mechanism of the actual synthetic molecular surface that provide the foundation for the non-linear dispersion. While the energies involved are spread spatially across a significant bandwidth, they form a perfect Nspectroscopic" signature of the complex interactions. These interactions are perfectly specific to the molecule, crystal or alloy.

Scattering of light with a non-linear shift in the resultant emissions in a conserved quantum mechanism was predicted as early as 1923, inspired by the discovery of the Compton effect The Raman effect was discovered experimentally in 1928 when it was shown that the spectrum of the scattered light of liquids and solids, strongly illuminated with monochromatic

light, contained frequencies which were not present in the exciting light Characteristically they were found to be specific of the IIpumped" media and when analyzed, provided a low energy specific indicator for constituent analysis.

During the 1960's, lasers (intense sources of monochromatic light), and their researchers did not take advantage of this non- linear event Raman scattering as it is called provided little more than a convenient error fudge for experimentation.

The experimentally confirmed laws of Raman scattering are as follows: (1) The pattern of Raman lines, expressed as frequency shifts from the exciting line, (delta vi i .. 1,2,3, •••... ) is independent of the exciting frequency. (2) The pattern of Raman frequency shifts, delta vi, is symmetrical about the exciting line, however, the line (Stoke lines) are always more intense than the corresponding lines on the high frequency side (and- stoke "lines). The ratio of the intensities of corresponding anti- Stokes and Stokes lines is la/ls-esp(-delta vi hc / kt), where the Raman shift delta vi is expressed as usual in cm-1. (3) A given Raman line shows a degree of polarization which depends on the origin of the line and on the experimental arrangement For strictfy transverse observation, i.e., observation at right angles of the incident light, the depolarization factor, rho n, has a value in the range 0 -6/7 for unpolarized incident light

It may be said that the Raman shifts, correspond to energy differences (in cm-l_ between discrete stationary states of the scattering system. Thus, in the quantum picture, the incident photons collide elastically with the molecules to give Rayleigh scattering, or inelastically to give Raman scattering, the latter process being much less probable that the former. For a Stokes Raman line, the photon furnishes energy to raise the molecule from a lower to a higher state; for an anti-Stokes line, the molecule must furnish energy to the scattered photon and move to a lower energy state. The and-Stokes line thus originates in a less highly populated state and is weaker than the corresponding Stokes line. The Raman process can be described classically, but not accurately, as the IImodulation of the scattered light wave by the internal motions of the scattering molecule. The Raman lines constituting sidebands of Rayleigh frequency.

As indicated herein; classical treatment would involve simple "modulationA' models to predict results. However, the normalized methodology to work through a common Raman spectroscopic teChnology would limit studies to the near infrared. This is mainly because of the normally weak Raman active molecules and their associated poor conversion qualities. In order to work on larger molecules and require smaller pump energies, new techniques have been devised to enhance the non-linear properties.

Significant enhancement has been studied through what is called SERS (Surface Enhanced Raman Scattering). Observed increases on the order of a factor of one million times Raman intensity for molecules absorbed on planar metallic surfaces. While several mechanisms appear to be at work in producing the enhancement, one of these mechanisms, known as the image field effect (IFE) considered the interaction between the oscillating dipole moment induced in the absorbed molecule and its image in the metal. This mechanism also appears under other conditions.

While the mechanism employed in MRX is not classically Raman Scattering, it does share a common foundation. Whereas, Raman scattering exists independent from the pump excitation energies and spatial image, MRX utilizes a pulsed spatially imaged bandwidth corresponding to the classical anti- Stokes line to form a collective surface plasmon excitation on the surface of the molecule. The molecule whose anti-Stokes line most dosely corresponds to that of the pump is said to be II coupled". the Coupled molecule absorbs the pump energy until saturation is reached several orders of magnitude more effldendy than other molecules of similar weight and configuration. Once saturation is reached, the Lumped Harmonic Oscillator, formed by the plasmon network, relaxes,. Upon relaxation, a pulse of energy (coherent though multi­frequency) is emitted. In effect a true Raman Laser. Albeit, microscopic in size and orthogonal in propagation, its characteristic emission is specific to the Coupled molecule.

When a substance is irr~diated by the radiation of a pulse laser and simultaneously by a continuum lying at frequencies higher than the tYpical Stokes lines, the r Raman shifts appear as absorbed lines.

This is the so-called inverse Raman effect. In this case, all the Raman active molecular transitions can appear in the spectrum. Since the spectrum is generated in liquids and solids in a time of approximately 45 nanoseconds and since there are the possibilities of redudng the time much further, the effect can furnish a high speed method for studying transient molecular phenomena as well as static ones. .

This image field produces an effective resonance condition for the laser frequency, giving the maximum enhancement of Raman scattering at "resonance".

MRX incorporates this Coupling condition in the soft X- Ray portion of the spectrum to interrogate a field. The specimen requires no preparation aside from the removal of all ferromagnetic material and electronic devices.

MRX Couples sufficient energy into the infectious or targeted molecules or mass to transform the phonon phonon interactions into phonon vibron interaction.

By Coupling energy directly into the molecular bond sites; a rupturing of several bonds occur, completely defeating any targeted molecules.

• ~e! .• '

-----------------------------------------------------------------------------------------------------------------------

;F2306 ~RX ~~~~~~ ?HOTCN:C ENERGY :0 :E:E:: --...... ~~~= AND -,:ANCERS AND :~MORS :~ V:VO

;F2307 ~RX REMCTE GEOLOGICAL SENSI~ - UTILIZES MAGNET:C AND PHOTONIC ENER­G~ES :~ ?:~PO!NT ANY ~!NERALY OR PE:ROtE~~ :E?CS:: A: ANY JE?!H.

;F2308 ~RX CHEMICAL-COC?LE , DIRECT ~~GNE!IC , ?HOTONIC ENERGIES :0 CATALYZE AND :O~TROL At: ORGANIC/:NOR~AN!C/PE:ROCHEMrCAL AND POLYMER PROCESSES.

1F2309 MRX ENV:RONMEN~A~ - CCUP:ES AND DIRECrS PHOTONIC AND MAGNETIC ENERGIES TO FULLY DEGRADE ALL HAZARDOUS ORGANIC/INORGANIC WASTES IN WATER/ArR/

1F2310 MRX DEFENSE - REMOTE PROJECTION OF MAGNETIC , PHOTONIC ENERGIES TO NEUTRALIZE CHEMICAL/BIOLOGICAL/NUCLEAR WEAPONS IN 0 TIME, STATIC/

1F2311 MRX DEFENSE - T~F. REMOTE, NON-DETECTABLE NF.UTRALIZATION OF NUCLEAR WEAPONRY.

1F2312 MRX DESALINATION - COUPLE AND DIRECT PHOTONIC AND MAGNETIC ENERGIES TO INEXPENSIVELY REMOVE DRINKING WATER FROM SEA WATER.

JF2313 MAX DEFENSE - REMOTE PROJECTION OF MAGNETIC , PHOTONIC ENERGIES TO DEACTIVATE SATELLITES AND AIRCRAFT IN 0 TIME.

C'

1F2314 MaX MOLECULAR MEMORY - UTILIZES X-RAY AND MAGNETIC ENERGIES TO ENCODE I DECODE BINARY AT MOLECULAR LEVEL IN 3 DIMENSIONS, RAM AND ROM.

JG0002 ADEC-on site radioactive remediation.

?:-oal:c::,cr.

Lab or Prot:otype i,;SA

Lab or Pr~totype USA

Lab or Prototype USA

Lab or Prototype :.iSA

Lab or Pr~co~ype USA

Lab or Prototype USA

Lab or Prototype USA

Lab or Prototype USA

Production USA

ANCILLARY TECHNOLOGIES & APPLICATIONS OF MRX

MRX is a virtual technology with transforming applications in Medicine, the Environment, Chemical Processing, Desalination, On Site Radioactive Remediation, Remote Sensing, Remote Neutralization with Molecular Speciflcity and it's many applications In Defense as a Lethal/Non-Lethal Weapons System and as a Disabling Technology.

MRX MEDICAL--couples and directs magnetic and photonic energy to detect and destroy targeted 'viruses, bacteria, fungi, cancers and tumors in vivo without side effects due to the absorption targeting achieving molecular specificity.

MRX ENVI RONMENT AL--couples and directs magnetic and photonic energies to fully degrade all hazardous organic and inorganic contaminates in water, soil and air.

MRX CHEMICAL--couples and directs magnetic and photonlc energies to catalyze and control the reactions of organic, Inorganic, petrochemical and polymer processes.

MRX DESALINATION--couples and directs magnetic and photonlc energies to inexpensively seperate drinking water from sea water in ultra high volumes.

MRX ADEC--the accelerated decay energy conversion is a system for making use of stimulated radioactive decay process toward the direct extraction of electrical energy. As the extration of power from the nuclear material Is accelerated, the materials natural emissive lifetime is exhausted in direct relation. The primary use for ADEC is NUCLEAR WASTE DISPOSAL. There is no existing technology in competition with ADEC.

GERARDO INTERNATIONAL '" "'.'tll "V"'CY c:o\.Jm

DA YTO:-t A 8ZAC'Il. n.. _lut·I'7'10

"t~tPWO""c eo. , 7S ... itle

ADEC-ACCEL.ERATED DECAY ENERCY CONVERTER

ADE'C is a system for- making use of stimulated radioactive decay process's tcwa rd .the direct extraction of electrical energy. When radionucf ides undergo spontaneous' stabJizing decay, energy is liberated fram the nucfeous. This energy occurs in Alpha, Beta and Ca.ma emission. The usable energy is coupled by means of a magnetic field associated with the charge particles moving at high velocities. Obviously, this process can return power when there exists a definite flux of the charged pardcles, suitably coupled. I n order to ensure a highly collimated stram of charged particles becomes incident through the active coupling aperture, shadow callimate the source to produce a pencil beam or stimulate emmissfan alang a spectlc transverse axis. This technicaUy simple geometric collimation reduces the available power from a source to a small aspect ratio. StImulated gain allows for twa enhancing attributes. It assures a high percentage of .... ission occurs along a specified axis and can produce hlghw fluxes of charged ~rtjcles. The physical mechanism of stimulated decay utilizes a precise injection of photons at energy Iwavelengths of sub-nud .. r sca'e. While the energy produced is very high, the power required is very law u the tnnsfer acc:urs in the space of i wavelength. The energy is recovered in the actual ejection coupling of the emitted partlc!e. When the ejection takes place, the intensity of the flux can be entrained by the geometry of theac:dve ejection region. This allows for a highly active and effedent saaUl aperture caupllng MCtion. The total amount of energy availabl. fram any unstable .urce is flxed in MOST situations. ADEC does not change the mechanism of spanmn.au. decay, It changes the probability of which atoms will undergo decay and when the decay will occur. As atoms exhibit no statistical memary, the ev.,t of • neighboring atom's spontaneous decay in no way Influences the likelihood or unlikelihood of decay of a selected atom. As the extraction at power fram the Nuclear material is accelerated, the material's natural emissive lifetime will be exhausted in direct relation.

APPLJCATIONS: Nuclear Waste Disposal and Utilization '. Universal Power Sources

Co-Generation Systems for Returning Power to Electrical Crids Primary Energy Sources for Instrumentation and Devices Space Platform Pow .. C ...... tars CritJcal Mass Abe,.,...tfan . Medical Treatment Radiation Detection Instrumentation and Sensors Nuclar Imaging TechniquM Short WaveLength Quantwn Devices

"k'A ::MRX can fully degrade all h~Zill'dous /toxic organic /inorganic wastes /chemicals in water lair /soil.

GEl~.\RDO INTERNATIONAL liZ WATtA TUAM£Y COURT

nA '-TON A BEACH. I'L .118·'''110

TtL.£P,",ON£ (!MM, 7"'8'.

PCB's - photonic catalyst solution.

A SAFE AND EFFECTIVE LOW COST SOLUTION TO ELIMINATINC PCS'S USINC MRX •

ThlJ -e' . - ". --------------,.~--1 ...... 'I

. ~ . _ ... T"~ p arT,,,.,. -for

. . ",0 st C'o-' t" .. ~" at(~ . SQ~'S ',. w.t,r

~ . s"""'''''-,.I.,,., .50\ ~ ~ -- a's -..... ---- - .. ------ . CI 'I f' J '" · .~

- , ~--- ~'s ....--. t'--="',,- ,1 -. - #IS,

.... ~.T........ .,. • ..-.to __ .... v~. _ . p" ... , o~ .'_" _. _ _ ~., __

Cl ttr , a" . VI _ .. _. __ .

c •• t t.,~~J ~.----._.-.

-.--.---- .. -..... --·------·-Cl~-S-:~-\...t ~f·~~·r ·ar·

• ) • Nt«"" Sit. rt~'t "" .- -~ ... -~ ""~1

~CCS$'-"~ T.'.·

.. C\ i., - . __ ._-.. --- .. - -. ··----------C-\-,--'~~ ..... __ . ~-~ .-.. -_._- ._- --...• -- .. ~.

c:, _. -- -~, ----- - - - . i 4--- ~ ~ .... ~.11

1· 4; -A-«-1( .--. --.. ----. ------- ~ .. I"(--\»~~!"~ Ira",)

. J.-l ---- -.. -- . ----------"'(\ - _. - . ---

----@-_ ... _ .. _ . .. . __ .... _--_ .. - _. c:' .. @ ---

.. " _.-- .---

J ~:"'-.~ -_ .. _ . c.,\..c CcaJ ,sc II

.,-:. ._--. __ . -- ---

)\ ~ .. -~~~~X

(-:.c. c.-Co

c, -----.---------00:--------

---_._.- ... --

------_._- .~--- . -_._. _ .. - 4- - ---®-_._ .. -_ .... _-: .~~ -. -~~~~-Jl :~\r-_ M-I.x -.

. c-c. . ---- ._- - - e~

-----

• A mathematically proven. perfected nnandal model to fund the heallh care system. One that was developed 5 years ago. in February 1989.

• Cradle to grave covenge (or every person in the Country. • Guaranteed univenal health coverage for everyone. • One monthly cost. the same for aU ages, 0 to 100+.

male or (emale. • IHT is not an Insurance Company. • nIT ls a nnancial hybrid of a capital corporation wilh the

dennitive solution to funding health care systems. without risk. in all countries.

• Pays 100% o( Preventive are. • Pays 1009'0 of Doctor -Bills. • Pays 100'% of Hospital Sills. • Pays 1009'0 of Chiropractic Care. • Pays 100% or Vision Care. • Pays 100% or Dental Care. • Pays 1009'0 or Prescriptions. • Pays 100% of Organ Transplanu.

Pays 100% ot Long Term Care. • Pays 100'-" of Catastrophic Care. • Pays 100% of Pre-natal Care. • Pays 100% of Mental Health Care. • Pays 100% or Vltamiru. • Pays 100% of Nutritional Supplemenu. • Replaces Medicare. • Replaces Medicaid. • Replaces Government Health Programs. • Replaen HMO·s. • Replaces Private Health Insurance.

Replact5 Group Health Insurance. Replaces Interim Health lruurance.

• Replaces MedJcare Supplement Insurance. • Replact5 the Inemden ... complex and contusing government

operated systems which are Itnandalty selt.-deteating. • No Deductible. • No co-payments. (included in monthly COlt) • No additional coverage nHded of any klocl. • You cboose your prorider -Doctor &: Hospital. • Absolutely no addltloaaJ costs beyond the monthly

payment. • Same day of service dectrollic transfer of twJds to

provlden. • Physician maintains complete control to provide

the highest quality care to pldeaL • Computer assisted system (or accurate diagnosis

for providers. It requested.. • No accounts rtteivable. • No (onns·Physicians spend all their lime practicing

medldne. not paperwork. • No bureaucratic control demanding mtrictJoDS on

providen. • No reduction In pronts. • No cost to businesses.

• 0 health care COlli to buslDea :::I lower production costs :: increased rneuue • more birina • more jobl:l; more competitive 10 International markets. ecooomJc growtb • iocrnsed productivity (rom workuswbo DO iooger wOIT7 o( total nnancial loss due to health tan! bills. iDcnued proRtabWty.

• No cost sbtrun .. • No new taxes. • No rrducdoQ of ctU'Tmt GonrDllleot benefit programs needed. • Total acceu to total c:ue with nzllldeat profitability to encourage

and promote tbe world', noen bealtb care syttem. • No paperwork (or prorider or patJenL • FlDandai awardl proYide a .ipitlC2Dt bJcentive to anyone oltering

sugestlom: (or continuous quallty maoagement to redudng cc:.u. implement or improve proced.uns, poUdes or practices while maintaining the blJhest quaUty care obtainable anywhere in the world.

• Th. prn..,tloa or mud wflboul CGII coatrols Is dl'ectlv.ly accompllsbed by ProYidlnl lb. bealth are provld.r Cull paym •• ' (.Iectrooically lraosftrftd !be ..... day orsemce) baed o. POll blUlo, pnctlces, d_ ....... pbla '" CIIrTeIII blWog practices oC all olb.r pby.ldaDl boopllalllproYid .... o!l'm .. !be ....... m...

• Fully computerized medical reeords, proCUes. drug promes. d.m"l"'pblcs, lIoaodal paym ...... deotal ..... nIs. all data '" commuaJcadoDa. n.aaadaI dllbUI"HIDcull ror 45.000+ phannacies aod 10.000+ boorpltall aDd medical cmten. Uolimited .xpaodablUty or lb. oymm. Capable or baoclllnilb. nnancial payments betwfftl161.l+ mUUoa padeaa and tbeir providers. FlnaodaI dlsbunao.., .. 10 J!O,OOO+ proC ... lonals on a daily bub by wire.. at Lime ot service., coacurrent with rectipt or service.

• INTERNATIONAL HEALTH TRUST pnmdn these services at 35'-"+ below the roll of c:uJ'ftIIt premiums.

For informaJio1llll inquiriel. conl4e/; Goorgo W. Williams @

9fJ4.756-1916 or flU 904-756-4300.

Gerardo International 112 Water Turkey Coun * Daytona Beach Florida 32119-8710 USA

Genesistic [ . - - - _.. ... .. _.. . .... .::...- - -

Reasoning !

New technologies are created by reassembling 2 or more elements of existing tech­nologies into new combinations and putting them to new uses.

Breakthrough technologies remain unrecognized for long periods of time because they are a combination of elements from diverse and previously unrelated industries, disciplines & strategies.

This creative process has been converted into a mathematical formula capable of systematically and comprehensively recognizing and successfully integrating new combinations of elements and their applications in previously unforeseen relation­ships between 9000+ global industries, 979 disciplines and all 78 game theory strate­gies.

The results of this "Genesistic Reasoning" formula provide the ability to consistently and reliably produce superior products, processes, applications and strategies.

To inquire how this successful integration is going to affect your industry and mar­kets or how it can assist you, your organization, agency or department; contact George W. Williams @ 904-756-1916 or fax 904-756-4300.

All the solutions, to all the problems, are just waiting .•••.•..• to be recognized.

t • • '. .' - - -. ~ ~ • ~ , ... • - ----=- -~

Gerardo International 112 Water Turkey Court * Daytona Beach Florida 32119-87/0 ' \ \

News

Release

Gerardo International seeks location in . Austria/or MRX Medical Facility

Daytona Beach, Florida - USA - Gerardo International desires a location in Austria for its Medical Facility. A separate Facility for ancillary applications of the MRX technology is also required.

Information Provided Includes:

* MRX-MEDICAL briefing. * Reuters news service article published in De Standaardl

Brussels. * MRX-DEFENSE: Vladimir Zhirinovsky's threat of

Elipton. * Zhirinovsky's Elipton threatens the security of Eastern

Europe and NATO. * MRX vs. Elipton. * Focus on medical applications. * Economic Impact in Austria. * Ancillary technologies and applications of MRX. * MRX-DEFENSE as an anti-offensive weapons deterrent

system effective against nuclear, chemical and biological weapons.

* United States Congressional Support. * MRX-ADEC: on site radioactive remediation of nuclear

waste. * MRX-ENVIRONMENTAL: on site remediation of all

hazardous and toxic waste in soil, air and water.

For Infonnational inquiries, contact: George W. Williams @ (904) 756-1916 or fax 904-756-4300.

Gerardo International 112 Water Turkey Court * Daytona Beach Florida 32119-8710 USA

JOHN L MICA 7ne OISTRlCf. Ft,oRfDA

COMMITTEE ON PUBUC WORKS AND TRANSPORTATION

S~MM~ONA~nCN

SUICQMMl1Tll ON ECONOMIC DIYILONUIT

GOVSIHMENT OPERATIONS

SUICDMMITTII ON ENVI"'lNMlNT. ENPGY AND NAnJlW. RUOURCIS

SUIICOMMITTEE ON HUMAN RlSOURClS AND INTDGOVUNMENTAL RlLAnDNI

fCongrtss of tfJt Itnittb 6tatts JljOUI£ af Btpr£l£ntatib£J

lIasbingtan. m~ 20515-0907

Ms. Ellie Carle Congressional Support Officer Central Intelligence Agency Office of Congressional Affairs Room 7BOO OHB Washington, DC 20505

Dear Ms. Carle:

January 4, 1994

.... y1O

C 427 CM .. HouII OfIIICI av..a.. WAlNIIIUGII. DC 20S' I

CZ021 22~031

C 237 FuJlWODD BLVD. Sum 101

Full PUIC. A. 32730 (C07) 331-8080

C 8CO DILTOIU. 8LVD. SumG

OaTOIU., A. 32725 (C07) 88G-14"

C 1388 DUfCLAWIOIl AVL Sum 28

Po", ClANGL Fl32127 (104. 758-9798

I am referring to your attention infor.mation relating to technology developed by my constituent, Mr. Neil Gerardo.

In specific, I would appreciate your consideration of Mr. Gerardo's initiative as a counter.measure to nuclear, chemical, and 'biological weapons ..

Mr. Gerardo's address is 112 Water Turkey Court, Daytona Beach, Fl 32119-8710. His phone number is (904) 756-1916, and he has indicated to me his availability for discussing potential uses for his technology.

Thank you for your attention to this matter.

With my regards and best wishes, I remain,

JLM:grb

Enclosure

Wastwpt 0 C.20S0S

Gerardo International 112 water Turkey Court Daytona Beach, Florida 32119-8710 '.

Attention: Mr. Neil Gerardo President

Dear Mr. Gerardo:

Your letter to the Honorable John Mica of Florida bas been forwarded to the Central Intelligence Agency for action.

Enclosures

Sincerely,

C:lUl J JL '~ .. /j:I~.-;I. Hess

Procurement Management Staff Office of Logistics

JOHN L MICA 7TH DIITIICT. FLORIDA

COMMITTEE ON PUBUC WORKS AND TRAHSPORTAnON

suaCOMMma ON AVlAT10N

SUICOMMmD ON ECONOMIC DEVI1.OPMENT

GOVERNMENT OPERAnONS

suaCOMMm'EI ON ENVIROMMENT. ENERGY AND NATURAl. RESOURCES

suaCOMMmtE ON HUMAN RlSOURCIS AND IHTERGOVIRNMINTAL RELAnoNS

fCORltftJJ of tfJe .nittb 6tattJ .OU't of l\tprt'tntatib~

lIa'bington, _~ 20515-0907

Mr. Neil Gerardo President . Gerardo International 112 Water Turkey Court Daytona Beach, Florida 32119

Dear Neil:

January 4, 1994

IIIPLYTO

o 427 CMIIOII HousI 0fRcIauu. WAIIn811MI. DC 20118

(2021221-4031

[J 237 FIawaoD kYO. SVIft 108

Fa. PAU. R. 32730 (407) 331-8080

[J 840 Oll.nHIA BlVD. SUrnG

DIL'"*Ao R. 32721 (407) 880-1411

[J 1311 OUMAwnHt AVL SUm 28

PoIIT OIWlGl. R. 32127 (804) 758-8711

I wanted to thank you for contacting me relating your technology to deactivate explosive devices. It was good to hear from you and I appreciate your taking the t~e to write me.

I agree with you that your technology may pose great benefits to our country. Its potential to eliminate the threat of nuclear, chemical and biological weapons would be an enor.mous help to our national security concerns and in particular in our fight against terrorism.

As my legislative aide, Gary Burns, discussed with you on December 14, I am happy to refer your technology to the Central Intelligence Agency. In addition, I will keep your initiative in mind should I find another agency that could utilize this type of technology. Enclosed please find a copy of my letter to the C.I.A.

I am pleased to be of assistance in this matter. Thanks again for writing me and please do not hesitate to contact me again if I can be of further assistance.

With my regards and best wishes, I remain,

JLM:grb

Enclosure

: ........... , .. , ........................................................................................... , ..................... . ,~"':' '~1 .,~.I 1':' '-'4· ................................................... . ~~. ~.... '-II' -:.J •••••••••••••••••

____ .... __ ----- ...... .....;' ---~ ....... ".-- -.., ... ' NO. 658 F=tl02/~eJ4

TAS5-03-01 0309EST(

m2007M027S b i RUSSIA-USA-AMES E220001 03-01 0237

RUSSIA-USA-AME9, , E220001, ZN42S

MOSCOW EVENING TV NEWS

.CIA OVERSTATING AMES A~FAIR TO GAIN ITS ENDS - iXP~~'S. 22/2 TASS 44

MOSCOW MARCH 1 TASS -- BY ITAR-1ASe CDRR&SpaNDcN1 AND~EI PALARIA:

EXPERTS OF THl RUSSIAN EXTiRNAL INlELLIBiNCE S&RUICE HAV~ DESCRIBED INFORMATION ABOUT A~DRICH HAZEN RM~a' CQMPLICIrV IN TRANSF&RRING TO RUSSIA TECHNDLOGY OF DEVk~DPtNB e BUe~8~&CkCT

,WEAPON NO MORE THAN AN ACTION OF THE AMERICAN SPECIAL ~eRVICES DESIBN&D TO ATTRACT MORE PUBLIC ATTENTION TO TH~ AMlS' A~~AIR.

AS EARLIER REPORTED, ~RESIDENT OF THE AMERICAN CORPQRATION . GERARDO INTERNATIDNAL N~IL BERARDO ,ANNOUNCED THA1 ALDRItH RM&S ARRESTED IN THE UNITED STATES ON SUSPICION OF SPVINB FOR MOSCOW COULD HAVE HANDED OVER TD MOSCOW SECRET INFDRMATION CONCERNINB THE MRX DEFENCE TECHNOLOGV INVENTED BV THE CDMPANV WHICH D~VELOPS SECRET W~ApON SYSTEMS ON ORDERS FROM THI PENTAION.

RUSSIAN SPECIALISTS DESCRIBE AS DISINFORMATION ALSO REPORTS ABOUT ALDRICH AM~S' COMPLICITY IN DRUG TRAFFICKINB. THi EXP~R'S SAY THAT THESE ARE TVPICAL DEVICES OF AMERICAN SPECIAL SERVICES AIMING AT INFLUENCING THE COURT.

EXPERTS SAY THAT THE REASONS FOR THESE AND SCME OTHeR ACTIONS ARE UNDERSTANDABLE BECAUSE, ACCDRDING TO INFORMATIDN AVAILABLE TO 'THE RUSSIAN EXPERTS, THE AMERICAN S~ECIAL SERVIC~S HAVE NO CONVINCING PROOF OF AMES' COMPLICITY IN SPVINB FOR MOSCOW.

ITEM ENDS

TASS-03-01 0319~a, (

c: Cl ?~ 16:~5 ............................................................................................

NO. 658 P004/ ~04 ...................... .

TASS-03-01 0717EST( MOSCOW EVENING TV NEWS

m2031M0470 u i RUSSIA-US-AMES-CASE E220001 03-01 0149

RUSSIR-U9-AMES-CASE, , E220001, ZT672

. RUSSIAN IN'E~LlaENCE EXPERTS CONSID~R AM~S CA~c INF~ A PLOY. 1/3 rASS 68A

MOSCOW MARCH 1 TABS - BY I1AR-TASSI EXPERTS FROM RUSSIA'S FOREIGN INTELLIGENCE SERVICE R£aA~D THE

PUBLICA1'ION OF INFORMATION ABOUT ALDRI~H AM&~' ALL~G&D .·INVULVc)'f1ENT IN THE 'TRANSFER OF TI::CHNQL013V ra RUSSIA '-:OR THE ;)EVEl:ePMENr-cF--A··-SUPt!'RSeeRE·T~eAPCN-AB-·A-"'BRt\fe-tf'UNCHt!n .. -Bv-tt;-S';--·-SECRET SERVICES WI'TH A VIEW TO ATTRACTING THE PUBLIC ArTt:;NTtoN TO THE +AM~S CASE+.

THE REASON FOR THIS AND OTHiR ACTIONS, THE RUSSIAN EXPER'S BE~IEVE, IS THE MORE UNDERSTANDAB~E AS, ACCORDING ra DArR AVAILABLE WITH TH&M, U.S. saCRET SERVICES SO FAR HAUk NO R~Al EVIDgNCE OF MR. AMES' INUOLYEMENT IN SPYING FOR RUSSIA.

ITEM ENDS

....................................................... ~ ....... . - ................................................•.................. 0.:. ... '01,-94 16: Q5 ................................................................. .

ma053M0&28 u i ZHIRINOVSKY-AMES E220ael e3-01 el~1

ZHIRINOVSKY-AMES. , E22e •• l, zwe,e .ZHIRINOVSKY DENIES AMES CONNECTION. 1/3 TRSS 121

NO. iSS

MOSCOW MARCH 1 TASS - BV %TAR-TASS CDRRESPONDiN1', RUSSIRN NATIONA~IST LEADER. VLADIMIR ZHIRINDVSKV DENtED

~LLEGATIONS THAT TH!: SiCRET WiAPONS WITH wHIcH HE HAD THHEA"E::N&:D THE" WEST OF ~ArE WAS OBTRINED BV RUSS1A THRDUGH ALDRICH AMeS, A HIGH-RANKING CIA OFFICIAL ARRESTE» ON CHARB~S OF SPVINW FOk RUSSIA.

+THESE CAN Bk PARALLEL RESkARCH WI1H SJM~LV 'H~ BAM. NAME. au, THIS IS A RESEACH UF OUR SCIENTlSrS. IT HAS NOrHING ra 00 WITH AMERICANS+, ZHIRINQVSKV TOLD TASS ON TUiSDAV AUDIN~ THA' H~ HAD LEARNED RBOUT THE AM~S FAMILY FROM NEWSPAPERS.

MEDIA RiPORTS SAID THAT TH~ ZHIRINOVB~V-D1SCLO~Eb SiC~i' ( WEAPON WAS CRERTED BV THE US +G~RARDO INTERNATIONAL+ COMPANY,

AND. ACCORDING TO ITS pREStbENl NEIL BERARDO, WAS OBiA1NEb By RUSSIANS THROUGH AMES.

+WE HAD AND HAVE NOTHING TO DO WITH THE AMES HUSBAND AND WIFE, AND WE ARE NOT CONNECTED WITH ANY SECRET SERVICES IN e~N~AAL+, ZHIRINOVSKV SAID.

ITEM ENDS

JOHN L, MICA 7TH O'Sf,"ef FLO/UDA

COMMITTEE ON PUBLIC WORKS AND TRANSPORTATION

SUBCOMM,TTEE ON AVIATION

SUBCOMM,TTEf ON ECOHOMIC DEVELOPMENT

GOVERNMENT OPERATIONS

SUBCOMMlmE ON EHVlflCNMENT ENERGY AND HA TURAL AESOURCES

Qtongrtll of tbt Itnittb 6tattl .oult of !\tprtltntatibtl

SUBCOMMITTEE ON HUMAN RESOURCES AHO INTERGovERNMENTAL REI..4T10HS

~ lIalbington t m~ 20515-0907

~.

Mr. Neil Gerardo Gerardo International 112 water Turkey Court Daytona Beach, FL 32119

Dear Mr. Gerardo:

March 8, 1994

~E"'." -J. = 427 c ...... o .. "'OU$( O",Cl 8uI\.0".G

WA$HI"GTO" DC 205' 5 12021 225-4035

C 237 FEII"wOOD 81.'10

SUITE 105 FEIIN PAIl.: FL 32730

14071 339-8080

o 840 OUTONA BLVO

o

SUITE G OELrONA, FL 32725

(407) 860-1499

1399 OUNUWTON AVE

SUITE lB POMT OIl"NGI, FL 32 1 27

(904) 758-9798

Thank you for your recent fax letter expressing your concerns about the security of your MRX defense technoloqy.

In order to be of assistance, I have forwarded a copy of your correspondence to the Central Intelligence Aqency and requested that they review the matter.

As soon as I receive a response from them, I will be back in touch with you.

with my reqards and best wishes, I remain,

..

ItRIHTlD ON IIICYCUD 'APa

e details with Brussels prior to our 'xt meeting to sign the final agree­ents. Getekend Neil Gerardo." tsULTAAT. Als Gerardo zijn be/oJ­, in de !romende maanden hard maakt, ag textielstad Koruijk zich op slag een .cJusief medisch centrum noemen in Jropa. Gerardo International wil er irn­ers <en soort ambulante Idiruek op­;hten, waarin een 50-tal units ofte 'ar!e kamers het geheel uitmaken. Pa­;nten die lijden aan kanker, HN -be­netting of andere levensgevaarlijke ",deerungen, kunnen eerst een diagno-

laten stellen (kostprijs 1500 VS-dol­r) om zich vervolgens te laten beha.n­:Ien op een heel ·karte periode (alles jeen zo'n half uur) tegen een prijs die ,hommelt tussen de 5000 en de 15.000 ,Uar. Het urueke aan een MRX-beha.n­:ling (uitgeveerd met laserstraai) is dat :t een resultaatsverbintenis betreft. of et andere woorden: het resultaat ordt verzekerd, tenrrunste als de ziekte . een vroeg stadium wordt onulelet 6n ,handeld. Zegt Neil Gerardo : "Het mkeronderzoek heef! zich tot hiertoe )Oral toegespitst op het verruetigen In de kwaadaardige cellen, iets wat !lfs in de huidige stand va.n het onder­)Ok maar vrij partieel is gelukt. Met IRX zijn wij anders tewerk geg...,. ereenvoudigd komt het hierop neer. IRX lOrgt ervoor dat de weg die de waadaardige cellen volgen, zonder ,eer wordt doorgeJrnip!, zodat ze de :>ede cellen nooit bereiken." In gespecializeerde Amerikaanse pu­

likaties wordt gezegd en geschreven at MRX de wetenschap op een hoger iveau heef! getild. Peter Piot (Instiruut oor Tropische Geneeskunde Antwer­en), een notoir HIV -specialist die 'erkt voor de Wereldgezondheidsorga­izatie in Gen~ve. staat er echter zeer ,eptisch tegenover : ,.Er is geen eokel ewijs dat die MRX-technologie effek­ef zou kunnen zijn als aids-bestrijder. .r zijn geen tests in kJinische omstan­igheden die dat aantonen." Krijgt Kort­jk dan een kat in een zak ? ·ROBLEK... MRX is ruet aileen toe­asbaar in de medische wereld, maar ok op ekonorrusch en militair-strate­isch vlak en is geen alleenbezit va.n ;erardo International - die vocr zijn itvinding g66n patent beef! aa.nge­raagd. ,.Dit zou de technologie tot pu­liek geheim hebben gemaakt. waar de efensie-industrie voordeel uit kan ha­,n," stelt Williams (zie kaderstuk). Villiarns verklaart gelijktijdig dat zijn reep op aanvraag van het Amerikaa.nse linisterie van Defensie de MRX-basis­,chnologie ook militair ontwikkelt. ~omt na de medische faciliteit mis­chien ook een militaire vestiging in :ortrijk ? Zegt Williams, formeel : Neen. onze prioriteit gaat uit naar de iekenzorg. We zijn beland in de faze "RENDS· 2A FEBRUARI 1 V94

van de commercializering van de uitviD­ding en hebben daarvoor Europa geko­zen. Waarom Amerika niet ? Heel een­voudig: nu MRX er is , zal dat een streep trekken door veel O&O-budget­ten van de machtige Amerikaanse far­

. ma-industrie. Of met andere woorden : Gerardo International kan beschouwd worden als een soort indringer. Vandaar dat we eerst naar Europa trekken. Lukt bet daar - en ruemand van ons die daaraa.n twijfelt - dan wordt de rode loper wei weer uitgereld in ons eigen land." SNKKUWIIAL. In het Kortrijkse is men beboorlijk onder de indruk van het multiplicator-effekt dat deze investering lOU kunnen meebrengen. De Gerardo­site op de universitaire campus zou niet aileen 500 jobs en een rruljardenomzet scheppen, maar een hele ekonorrusche sneeuwbal aan het roUen brengen. De 3500 square Jeet grote MRX-Idiniek zou non-stop open zijn. het hele jaar door. Ook de indirekte weerslag van de

Amerikaa.nse investering lOU zich snel laten gevoelen in het Texas van Vlaan­deren.

Het Kortrijkse gemeentebestuur is zich bewust van de potentiele impact. Voorai schepen Emmanuel de Bethune, verantwoordelijk voor externe betrek­kingen. werpt zich op als pleitbezorger Dummer een.

De Bethune wi! deze "gelOndheids­kuur" evenrueel ook laten terugbetalen door de sociale zekerheid en bij pro­beert in Brussel geboor te vinden. Vol­gens Luk De Busschere, die zich aI maandeolang met dit dossier iniaar, heef! de stad Kortrijk als dusdanig geen enkele incentive aangeboden aan de ,.rijke oom" uit Amerilca Neil Gerardo : ,,Incentives waren voor ons niet belang­rijk. Het was ons vooral om een centrale ligging in Europa Ie deen en Koruijk beantwoordt aan die voorwaarde. Incen­tives zijn meestal een bewijs van de zwakte van een regio,"CATHY BUYCK

KARI:L CAMSIIEN •

EKONOMIE 8: ONDERNEMEN 31

I BERICHT:

Roll.

rax AaI: NBI£ CVCR4RIXJ

IIIdrijf: GBRIRDO JJmIII1U2m1W, Tel: PaZ:

Vam l1iiiiOW *MC,.. Beddjf: S.P.&

Tel: 02/.1171030 Paz: 02121881.

OD ..... p:

t:.

I

News

Release

Gerardo International seeks location in Kortrijk, Belgiullzfor MRX Ll1edical Facility

, '

Daytona Beach, Florida· USA· Gerardo International desires a location in Kortrijk, Belgium for its Medical Facility. A separate Facility for ancillary applications of the MRX technology is also required.

Information Provided Includes:

* MRX·MEDICAL briefing. * Reuters news service article published in De Standaardl

Brussels. * MRX·DEFENSE: Vladimir Zhirinovsky's threat of

Elipton. * Zhirinovsky's Elipton threatens the security of Eastern

Europe and NATO. * MRX vs. Elipton. * Focus on medical applications. * Economic Impact in Kortrijk, Belgium. * Ancillary technologies and applications of MRX. * MRX·DEFENSE as an anti-offensive weapons deterrent

'system effective against nuclear, chemical and biological weapons.

* United States Congressional Support. * MRX·ADEC: on site radioactive remediation of nuclear

waste. * MRX·ENVIRONMENTAL: on site remediation of all

hazardous and toxic waste in soil, air and water.

For Informational inquiries, contact: George W. Williams @ (904) 756-i916 or fax 904-756-4300.

Gerardo International 112 Water Turkey Court * Daytona Beach Florida 3211 9·,, - : USA

DEPARTMENT OF HEALTH &. HUMAN SERVICES

Gerardo International Attn:· Neil Gerardo 112 Gray Dove Court Daytona Beach, Florida 32119

Re: K9l5545 Instrumentation for the Cure of Aids Dated: November 14, 1991 Received: December 11, .. 1991

Dear Mr. Geraldo:

Public Health Service

Food and Drug Administration 1390 Piccard Drive Rockville MD 20850

We have reviewed your Section 5l0(k) notification of intent to market the device referenced above. We cannot determine if the device is substantially equivalent to a legally marketed predIcate device based soieiy on the information you provided. To complete the review of your submission, we require the following information:

Your submission does not include the information required in a section 5l0(k) notification. You must identif a Ie all marketed redicate device which is substantially equiva ent to your device, and provide evidence to support your claim of substantial equivalence. To obtain guidance regarding the required content for a 5l0(k) notification, please contact our Division of Small Manufacturer's Assistance at their toll free number (800) 638-2041 or at (301) 443-6597.

r.o determj~p' wherheT nr n~t marketed predicate device

veness.

~ou may not market provided ade uate information described a ove an requ re y ) and (h), and you have received a letter from the Food and Drug Administration allowing you to do so. If you market the device without conforming to these requirements, you will be in violation of the Federal Food, Drug, and Cosmetic Act (Act). You may, however, distribute this device for investigational purposes to obtain clinical data if needed to establish substantial equivalence. Clinical investigations of this device must be conducted in accordance with the investigational device exemptions (IDE) regulations.

If the requested information is not received within 30 days, we will consider your premarket notification to be withdrawn and your submission will be deleted from our system. If you submit the requested information after 30 days it will be consid~red and process~d as R new 510(k); therefore, all information previously submitted must be resubmitted so that your new SlO(k) is complete.

Page - 2 - Mr. Neil Gerardo

Please submit the requested information to:

Document Mail Center (HFZ-40l) Center for Devices and Radiological Health Food and Drug Administration 1390 Piccard Drive Rockville, Maryland 20850

If you have any questions concerning the contents of this letter, please contact Loren Zaremba at (301) 427-1212. If you need information or assistance concerning the IDE regulations, please contact the Division of Small Manufacturers Assistance at their toll free number (800) 638-2041 or at (301) 443-6597.

Sincerely yours,

f;~d.,~ Lillian Yin, Ph.D. Director, Division of Reproductive,

Abdominal, Ear, Nose and Throat, and Radiological Devices

Office of Device Evaluation Center for Devices and

Radiological Health

DBPARTMBHT or &BALTB ARD IIUIWf SERVICES

DECEMBER 12, 1991

GERARDO INTL. ATTN: NEIL GERARDO 112 GRAY DOVE COURT DAYTONA.~BACB, PL 32119

Public Health Service

Food aad Drug AdaiDistratioa Ceater for De.iee. aDd aadiologieal aealtb Offiee of Deviee Bvaluatioa Doeu.eDt Rail CeDter (BFS-40l) 1390 Pieeard Driv. aoekYill., RarylaDd 20150

510(k) Number: K915545 Received: 12-11-91 Product: AIDS DETECTION

DEVICE

Ve have received the Premarket Notification you submitted in accordance with Section 510(k) of the Pederal Pood, Drug, and Cosmetic Act (Act) for the above referenced product. Ve have assigned your submission a unique 510(k) number that is cited above. Please refer prominently to this 510(k) number in any future correspondence that relates to this submission. Ve will notify you when the processing of your premarket notification has been completed or if any addi tional in.f~rmation is required.

The Safe Medical nevices Act of 1990 (SMDA), signed on November 28, states that you may not place this device into commercial distribution until you receive a letter from PDA allowing you to do so. As in the past, we intend to complete our review as quickly as possible. Generally we do so within 90 days. However, the complexity of a submission or a requirement for additional information may occasionally cause the review to extend beyond 90 days. Thus, if you have not received a written decision or been contacted within 90 days of our receipt date, you may want to check with PDA to determine the status of your submission.

In addition, the SHDA requires all persons submitting a premarket notification submission to include either (1) a summary of the safety and effectiveness information in the premarket notification submission upon which an equivalence determination could be based (510(k) summary), OR (2) a statement that safety and effectiveness information will be made available to interested persons upon request (510(k) statement). Safety and effectiveness information refers to information in the premarket notification submission, including adverse safety and effectiveness information, that is relevant to an assessm~t of substantial equivalence. The information could be descriptive information about the new and predicate device(s), or performance or clinical testing information. Ve cannot issue a final decision on your 510(k) unless you comply with this requirement.

Although PDA acknowledges that the law provides the 510(k) submitter an alternative, FDA encourages manufacturers to provide a 510(k) statement to FDA and to make their safety and effectiveness information available to the public, excluding confidential manufacturing process information, in lieu of submitting a 510(k) summary to the agency until FDA promulgates a regulation on the content and format of.~10(k) summaries. Since the lav

requires that FDA .ost aske the 510(k) suaaary, or the source of inforaation referred to in the 510(k) stata.ent, publicly available vithin 30 days of making a substantial equivalence dete~ination, ve advise you that ve .. y no longer honor any request for extended confidentiality under 21 CPR 807.95.

Additionally, the new legislation 'also requires any person who asserts that a device is substantially equivalent to a class III device to (1) certify that he or she has conducted a reasonable search of all information known, or otherwise available, about the generic type of device, AND (2) provide a summary description of the types of safety and effectiveness problems associated with the type of device and a citation to the literature, or other sources of information, upon which they have based the description (class III summary and certification). The description should be sufficiently comprehensive to demonstrate that an applicant is fully aware of the types of problems to which the device is susceptible. If you have not provided this class III summary and certification in your premarket notification, please provide it as soon as possible. Ve cannot complete. 'the review of your submission until you do so.

Furthermore, the new legislation, section 522(a)(1), of the Act, states that if your device is a permanent implant the failure of which may cause death, you may be subject to required postmarket surveillance. If the premarket notification for your device was originally received on or after November 8, 1991, is subsequently found to be substantially equivalent to an Aneurysm Clip, Annuloplasty Ring, Artificial Embolization Device, Automatic Implanted Cardioverter Defibrillator System, Cardiovascular Intravascular Filter, Cardiovascular Permanent Pacemaker Electrode (Lead), Central Nervous System Fluid Shunt, Coronary Vascular Stent, Implantable Pacemaker Pulse Generator, Implanted Diaphragmatic/Phrenic Nerve Stimulator, Intracardiac Patch or Pledget, Intravascular Occluding Catheter, Replacement Heart Valve, Total Artificial Heart, Tracheal Prosthesis, Vascular Graft Prosthesis (less than 6 mm diameter), Vascular Graft Prosthesis (6 mm or greater diameter), Vena Cava Clip, or Ventricular Assist Device - Implant, you will be subject to the required postmarket surveillance and so notified of this determination in your substantially equivalent letter. (Some of the above listed types of devices may require a premarket approval application). This list is subject to change without notification. If you have any questions as to whether or not your device may be subject to postmarket surveillance or about this program, please contact Ms. Anita Rayner at (301) 443-7120.

Please note that the SMDA may have additional requirements affecting your device. You will be informed of these requirements as they become effective.

Please remember that all correspondence concerning your submission MUST be sent to the Document Mail Center (HFZ-401) at the above. letterhead address. Correspondence sent to any address other than the Document Mail Center will not be considered as part of your official premarket notification submission. Because of equipment and personnel limitations we cannot accept telefaxed material as part of your official premarket notification submission, unless specifically requested of you by an FDA official.

If you have procedural or policy questions, please contact the Division of Small Manufacturers Assistance at (301) 443-6597 or their toll-free number (800) 638-2041, or contact me at (301) 427-1190.

~~::::,~w Robert I. Chissler Chief, Premarket Notification Section Office of Device Evaluation Center for Devices and

Radiological Health

DEPARTMENT OF HEALTH &. HUMAN SERVICES Public Health Service

National Institutes of Health National Institute of Allergy and Infectious Diseases Bethesda, Maryland 20892

December 22, 1992

Mr. Neil Gerardo President Gerardo International 112 Water Turkey Court Daytona Beach, FL 39119-9710

Dear Mr. Gerardo:

This is in response to your December 2 letter to Dr. Louis Sullivan, Secretary, Department of Health and Human Services, regarding the 150 MRX Medical Device, a product·that is being manufactured by your company as a potential technique for eradicating the HIV virus in vivo. Because the National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health (NIH), has the major responsibility in the Federal government for basic and clinical research on AIDS, your letter was referred to my office for reply.

NIH supports opportunities for this type of methodology through the Small Business Innovation Research (SBIR) program. If Gerardo International is interested in obtaining federal funding to support its research, we would encourage you to submit a grant application to the SBIR program. As such, I have an enclosed an application which includes information about the program. If you have any further questions regarding the SBIR program you may contact the followi~g:

Office of Grants Inquiries Division of Research Grants National Institutes of Health 5333 Westbard Ave., Room 449 Bethesda, MD 20892 (301) 496-7441

Thank you for your interest in the AIDS research programs of the NIH. The AIDS epidemic is of the highest concern to those of us in the Public Health Service. We hope that with the dedication of medical researchers around the world, we can fi~~ ways to prevent, treat, and cure this devastating disease.

Enclosure

Sincerely yours,

~ Diane Shartsis Wax Chief, Policy Analysis and

Legislation Branch National Institute of Allergy

and Infectious Diseases

DEPARTMENT Of HEALTH & HUMAN SERVICES

DEC 2 1991

Mr. Neil Gerardo President Gerardo International 112 Gray Dove Court Daytona Beach, Florida 32119

Dear Mr. Gerardo:

PublIC Heattn SeMce

Food and Drug Administration 1390 Piccard Drive Rockville. MD 20850

This will acknowledge receipt of your November 14, 1991 letter to me requesting approval for marketing an AIDS device.

I have forwarded your submission to Mr. Robert Sheridan, Director of the Office of Device Bvaluation (ODE), which is responsible for handling all requests for approvals. Any further correspondence ahould be directed to ODE at the address noted above.

CONFIDENTIALITY AGREEMENT

THIS AGREEJ\\ENT is made on _________________________ _ between Gerardo International and _________________________ ,("Receiver")

and is effective as of the date set forth above. The parties acknowledge the following facts:

A. Gerardo International and Receiver desire to engage in a business relationship as described on Schedule I attached hereto (the "Project"); and

B. In order to evaluate and. if appropriate. to proceed with the Project. Gerardo International must disclose to Receiver certain Proprietary Information (as hereinafter defined). including without limitation the information described in Schedule II attached hereto.

In consideration of the above premises and the covenants hereinafter set forth. the parties agree as follows:

1. (a) As used herein. the term "Proprietary Information" means information related to the business of Gerardo International. its affiliates or the Project which (I) derives economic value. actual or potential. from not being generally known to or readily ascertainable by other persons who can obtain economic value from its disclosure or use; and (2) is the subject of efforts by Gerardo International or its affiliates that are reasonable under the circumstances to maintain its secrecy. including without limitation (i) marking any information reduced to tangible form clearly and conspicuously with a legend identifying its confidential or proprietary nature: (ii) identifying any oral presentation or communication as confidential immediately before. during or after such oral presentation or communication: or (iii) otherwise treating such information as confidential. Assuming the criteria in clauses (I) and (2) above are met. Proprietary Information includes. but is not limited to. technical and nontechnical data related to the formulas. patterns. designs. compilations. programs. inventions. methods. techniques. drawings. processes. finances. strategies. applications. actual or potential customers and suppliers. research. development. existing and future products. and employees of Gerardo International and its affiliates. Proprietary Information also includes information which has been disclosed to Gerardo International or its affiliates by a third party. which must be treated as confidential.

(b) Proprietary Information does not include any information which (I) is already known to Receiver at the time it is disclosed to Reciver: (2) is disclosed by Receiver pursuant to a requirement of a governmental agency or of law without simular restrictions or other protections against public disclosure or is required to be disclosed by operation of law: provided. however. that Receiver shall first have given written notice of required disclosure to Gerardo International. made a reasonable effort to obtain a protective order requiring that the Proprietary Information so disclosed be used only for the purposes for which disclosure is required and taken reasonable steps to allow Gerardo International to seek to protect the confidentiality of the information required to be disclosed; or (3) before being diwlged by Receiver (i) has become generally known to the public through no wrongful act of Receiver: (ii) has been rightfully received by Receiver from a third party without restriction on disclosure and without breach of an obligation of confidentiality running directly or indirecdy to Gerardo International (iii) has been approved for release to the general public by a written authorization of Gerardo International; (iv) has been independendy developed by Receiver without use. direcdy or indirecdy. of the Proprietary Information: or (v) has been furnished to a third party by Gerardo International without restrictions on the third party's right to disclose the information.

2, Receiver (a) must receive and hold the Proprietary Information in trust and in strictest confidence: (b) must protect the Proprietary Information from disclosure and in no event take any action causing. or fail to take the action necessary in order to prevent. and Proprietary Information disclosed to Receiver by Gerardo International. or developed by Receiver for Gerardo International. to lose its character as Proprietary Information: and (c) must not use, reproduce. distribute. disclose or otherwise disseminate the Proprietary Information except to perform the Project Any and all reproductions of the Proprietary Information must prominendy contain a confidentality legend.

3. Disclosures of the Proprietary Information may be made only to employees. agents or independent contractors of Receiver (a) who are direcdy involved in performing the Project and have a specific need to know such information: and (b) whom Receiver has obligated under a confidentiality agreement in the form of Schedule III attached hereto to hold the Proprietary Information in trust and in strictest confidence subject to the terms of this Agreement Receiver agrees to diligendy·monitor and enforce each such confidentiality agreement and. upon request by Gerardo International. prompdy to furnish to Gerardo International an executed and certified copy of each such agreement and a certified list of Receiver's employees. agents and independent contractors having had access to the Proprietary Information.

4. Within ten (10) days following the receipt of a written request from Gerardo International. Receiver must deliver to Gerardo International all tangible materials containing or embodying the Proprietary Information. together with a certificate executed by the president or any vice president of Receiver certifying that all such materials in Receiver's possession have been delivered to Gerardo International.

5. If Receiver should breach or threaten to breach any of the provisions of this Agreement. Gerardo International. in addition to any other remedies it may have at law or in equity, will be entided to a restraining order. injunction or other similar remedy in order to specifically enforce the provisions of this Agreement Receiver specifically acknowledges that money damages alone would be an inadequate remedy for the in;uries and damage which would be suffered and incurred by Gerardo International as a result of a breach of any of the provisons of this Agreement In the event that Gerardo International should seek an in;unction hereunder, Receiver hereby waives any requirement that Gerardo International submit proof of the economic value of any Proprietary Information or that Gerardo International post a bond or any other security,

6. Receiver represents and warrants that any information disclosed by Receiver to Gerardo International is not confidential to Receiver or to any third party. Accordingly, no obligation of any kind is assumed by or to be implied against Gerardo Interntional by viture of any information received (in whatever form or whenever received) from Receiver relating to the subject matter hereof. and Gerardo International is free to reproduce. use and disclose to others such information without limitation. Receiver understands and acknowledges that Gerardo International may now market or have under development products which are competitive with products or services now offered or which may be offered by Receiver. and the parties' communications here under will not serve to impair the right of Gerardo International to develop. make. use, procure or market products or services now or in the future which may be competitive with those offered by Receiver. nor require Gerardo International to disclose any planning or other information to Receiver.

7. This Agreement and the rights and obligations of the parties under the Agreement may be assigned only upon the prior written approval of the parties. The rights and obligations of the parties will inure to the benefit of. will be binding upon and will be enforceable by the parties and their lawful successors and representatives.

8. The duration of this agreement is for 100 (one hundred) years from the effective date. Neither expiration nor termination in any fom shall release Receiver from any and all obligations set forth in this agreement. including, but not limited to: confidentiality, disclosure. transfer and/or communications: which remain the valuable property of Gerardo International.

9. The Receiver shall not transfer or export: direcdy or indirecdy: any United States Source Data acquired from Gerardo International to any country for which the United States Government or any Agency thereof requires. at the time of Export. an export license or approval. without first obtaining such license or approval. At no time will the Receiver transfer any information in any form which would be in violation of United States Law as set forth by Presidential Orders. The State Department. The Commerce Department. The Department of Defense. The Department of Energy or any AGENCY OR DEPARTMENT of the Government of the United States. ANY attempt or approach from a third party to compromise any aspect of this agreement obligates Receiver to immediately inform Gerardo International of the attempt. method and parties involved: and assist. to the best of Receivers abilities. Gerardo

International and any AGENCY OR DEPARTMENT of the United States Government in providing information.

10. No modifications of this Agreement or waiver of any of its terms will be effective unless set forth in a writing signed by the party against whom it is sought to be enforced. This Agreement will be governed by and construed in accordance with the laws of the state of Florida.

RECEIVER: GERARDO INTERNATIONAL

By. ________________ __ By. ________________ __

Tide: ________________ _ Tide: ________ _

... l. 11

SCHEDULE I

DESCRIPTION OF THE PROJECT

The Project entails discussions and any subsequent agreements between the parties concerning PROJECT # _________ ..... i the sole and valuable property of Gerardo International. including. but not limited to:

which will be more fully detailed to Receiver following the execution of this agreement by the parties. ...

" " ...

SCHEDULE II

DESCRIPTION OF PROPRIETARY INFORMATION

Proprietary Information includes. but is not limited to. the existence. specifications. features. benefits. related documentation. tangible and intanglible forms of released and unreleased. in whole or in part. the transference and communication in any form or degree of. information. technologies. products. processes. prototype. know-how. samples. applications. projects. programs. technical data. non-technical data. patterns. designs. compliation. inventions. drawings. algorithms. schematics. equations. knowledge. technique. materials. strategies and intellectual property. including the creation. application and control of each: also including the finances. intellectual capital. employees. agents. independent contractors and affiliates of Gerardo International and the existence. nature and details of Gerardo International's relationship with Receiver.

SCHEDULE III

CONFIDENTIALITY AGREEMENT (Employee. Agent or Independent Contractor)

THIS AGREEMENT is made as of . between each of the individuals executing the Agreement under the heading "Employee. Agent or Independent Contractor": at the end of the Agreement. severally and not joindy (each such individual being referred to herein as "Employee"). and ___________ _ ("Receiver"). and is effective as of . The parties acknowlege the follOWing facts:

A. Receiver and Gerardo International desire to engage in a business relationship (the "Project"): and

B. In order to protect any Proprietary Information disclosed to Receiver by Gerardo International. or developed by Receiver for Gerardo International. in connection with the Project. Gerardo International and Receiver have entered into a confidentiality agreement dated as of (the II Agreement"). a copy of which is attached hereto as Exhibit A and by this reference incorporated herein. All capitalized terms used herein without defination shall have the meaning set forth in the Agreement.

In consideration of the above premises and the covenants hereinafter set forth. the parties agree as follows:

I. Employee (a) must receive and hold the Proprietary Information in trust and in strictest confidence: (b) must protect the Proprietary Information from disclosure and in no event take any actions causing. or fail to take the action necessary in order to prevent. any Proprietary Information to lose its character as Proprietary Information: and (c) must not use. reproduce. distribute. disclose or otherwise disseminate the Proprietary Information except in cOMection with the Project Any and all reproductions of the Proprietary Information must prominendy contain a confidentialty legend.

2. This Agreement. although between Employee and Receiver. will be fully enforceable in every respect. at law or in equity. by Gerardo International as a third party beneficiary hereunder.

3. If Employee should breach or threaten to breach any of the provisions of this Agreement. Receiver and Gerardo International. in addition to any other remedies they may have at law or in equity. will be entided to a restraining order. injunction or other similar remedy in order to specifically enforce the provisions of this Agreement. Employee specifically acknowledges that money damages alone would be an inadequate remedy for the injUries and damages which would be suffered and incurred by Receiver and Gerardo Interntional as a result of a breach of any of the provisions of the Agreement. In the event that Receiver or Gerardo International should seek an injunction hereunder. Employee hereby waives any requirement that Receiver or Gerardo International submit proof of the economic value of any Proprietary Information or that Receiver or Gerardo International post a bond or any other security.

4. No modifications of this Agreement or waiver of any of its terms will be effective unless set forth in a writing signed by the party apinst whom it is sought to be enforced. This Agreement will be governed by and construed in accordance with the laws of the state of florida.

RECEIVER:

By. __________________________ _

Tide: _____________ _

EMPLOYEE. AGENT OR INDEPENDENT CONTRACTOR

Signature'

Typed Name'

Affiliation:

Title:

Date Signed:

EMPLOYEE. AGENT OR INDEPENDENT CONTRACTOR

Signature'

Typed Name'

Affiliation:

Title:

Date Signed:

EMPLOYEE, AGENT OR INDEPENDENT CONTRACTOR

Signature:..' --------------

Typed Name:..' -------------

Affiliation::--------------

Title:----------------

Date Signed:, ____________ _

EMPLOYEE, AGENT OR INDEPENDENT CONTRACTOR

Signature'

Typed Name'

Affiliation:

Title:

Date Signed:

EMPLOYEE. AGENT OR INDEPENDENT CONTRACTOR

. Signature'

Typed Name'

Affiliation:

Title:

Date Signed:

EMPLOYEE, AGENT OR INDEPENDENT CONTRACTOR

Signature ... ' _____________ _

Typed Name:-' _------------

Affiliation::--------------

TitJe:----------------

Date Signed:, ____________ _